Other diseases of the respiratory system

J10_RESPOTHER

respiratory system disease: A non-neoplastic or neoplastic disorder that affects the respiratory system. Representative examples include pneumonia, chronic obstructive pulmonary disease, pulmonary failure, lung adenoma, lung carcinoma, and tracheal carcinoma.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

7644

4. Check minimum number of events

None

7644

5. Include endpoints

8822

6. Filter based on genotype QC (FinnGen only)

8822

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 77564 32394 43783
Only index persons 53570 24149 29421
Unadjusted period prevalence (%)
Whole population 1.10 0.93 1.22
Only index persons 1.02 0.89 1.12
Median age at first event (years)
Whole population 66.75 67.54 66.14
Only index persons 66.54 67.19 66.01

-FinnGen-

Key figures

All Female Male
Number of individuals 8822 3302 5520
Unadjusted period prevalence (%) 1.94 1.13 2.43
Median age at first event (years) 66.84 63.70 68.72

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
7888
Matched controls
78872
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J96.0
ICD-10 Finland
Acute respiratory failure
2469.7
323.0
1660
9
R03DA04
ATC
theophylline; systemic, rectal
4.9
323.0
1246
2931
C03CA01
ATC
furosemide; systemic
3.3
323.0
4330
21115
XG466
NOMESCO Finland
Sleep oxymetry
10.9
323.0
908
926
R06.0
ICD-10 Finland
Dyspnoea
3.7
323.0
3309
13001
I50.9
ICD-10 Finland
Heart failure, unspecified
3.3
323.0
2463
9437
WX725
NOMESCO Finland
Noninvasive ventilation
8.5
323.0
1007
1327
R5140
NOMESCO Finland
Monitoring the use of the aid
4.2
323.0
1452
4033
J98.0
ICD-10 Finland
Diseases of bronchus, not elsewhere classified
1560.0
323.0
435
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.2
323.0
2485
7835
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.8
323.0
1639
5075
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
4.0
323.0
1634
4835
UGC12
NOMESCO Finland
Flexible bronchoscopy
6.2
323.0
1825
3633
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
9.1
323.0
1594
2127
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.2
323.0
4022
15797
J98.6
ICD-10 Finland
Disorders of diaphragm
+∞
323.0
489
*
J96.1
ICD-10 Finland
Chronic respiratory failure
16384.0
323.0
2996
*
J45.9
ICD-10 Finland
Asthma, unspecified
3.4
323.0
2113
7734
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
36.0
323.0
465
137
J98.1
ICD-10 Finland
Pulmonary collapse
740.3
323.0
679
10
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
6.3
323.0
2718
6110
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
12.1
323.0
1188
1143
J96.9
ICD-10 Finland
Respiratory failure, unspecified
671.3
323.0
621
10
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
6.6
323.0
1315
2306
H02AB06
ATC
prednisolone; systemic
3.2
323.0
4867
26270
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
4.2
323.0
2857
9371
51925
ICD-8 Finland
Other diseases of respiratory system, Infiltratio pulmonis NUD
+∞
323.0
408
*
R03AC02
ATC
salbutamol; inhalant
3.4
323.0
5002
26626
R03BB04
ATC
tiotropium bromide; inhalant
6.5
323.0
2456
5122
R03AK06
ATC
salmeterol and fluticasone; inhalant
4.9
323.0
2369
6376
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
312.1
4274
25542
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.6
306.8
1187
2929
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
5.3
302.0
1009
2125
5188X
ICD-9 Finland
Other diseases of lung
+∞
280.8
268
*
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
4.0
261.3
1190
3390
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
5.4
254.0
827
1675
J01MA14
ATC
moxifloxacin; systemic
3.8
251.2
1203
3572
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
17.5
248.1
401
241
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.3
247.5
1443
5004
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.7
233.7
1893
8141
XG410
NOMESCO Finland
Flow-volume spirometry
5.6
233.6
736
1429
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
10.8
230.3
462
453
R03BA05
ATC
fluticasone; inhalant
2.8
229.7
1788
7496
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.6
227.3
2047
9346
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.6
226.6
867
2080
G47.3
ICD-10 Finland
Sleep apnoea
2.6
218.7
1960
8891
I50.0
ICD-10 Finland
Congestive heart failure
3.2
218.7
1317
4638
R03BB01
ATC
ipratropium bromide; inhalant
4.3
209.1
850
2156
R03AK07
ATC
formoterol and budesonide; inhalant
2.7
205.8
1694
7281
R95
ICPC
Chron obstructive pulmonary disease
6.6
205.0
563
914
WX722
NOMESCO Finland
PEEP
4.6
201.8
756
1767
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.2
198.2
1209
4271
R03AC12
ATC
salmeterol; inhalant
4.3
191.5
775
1951
J98.5
ICD-10 Finland
Diseases of mediastinum, not elsewhere classified
+∞
189.3
181
*
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
13.0
186.6
340
272
WX730
NOMESCO Finland
Conventional respirator
9.0
185.1
408
473
R02
ICPC
Shortness of breath/dyspnoea
2.9
182.6
1315
5168
J01MA12
ATC
levofloxacin; systemic
2.4
182.3
1997
9929
J45.1
ICD-10 Finland
Nonallergic asthma
3.6
180.1
886
2645
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
6.8
170.8
453
698
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
12.7
169.3
311
253
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.8
165.8
500
911
C03DA01
ATC
spironolactone; oral
2.7
165.6
1354
5716
C07AB07
ATC
bisoprolol; oral
1.9
162.6
4374
31123
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.9
159.1
3690
24804
R03BA02
ATC
budesonide; inhalant
2.4
158.5
1565
7305
GD1AD
NOMESCO Finland
Thorax CT examination
4.4
156.9
606
1448
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
5.6
154.7
480
904
WX892
NOMESCO Finland
Monitored bed care
3.1
150.2
929
3269
J01AA02
ATC
doxycycline; systemic
2.0
150.0
5962
48117
J46
ICD-10 Finland
Status asthmaticus
6.1
149.6
433
748
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
5.4
147.2
467
902
WX721
NOMESCO Finland
Oxygen concentrator therapy
144.6
146.8
156
11
TPH07
NOMESCO Finland
Cathetrisation of artery
2.7
144.9
1135
4639
R03BA01
ATC
beclometasone; inhalant
2.4
139.7
1337
6098
J98.4
ICD-10 Finland
Other disorders of lung
180.6
136.0
142
8
TGC00
NOMESCO Finland
Bronchial lavation
5.4
131.5
419
812
R28
ICPC
Limited function/disability (R)
9.3
131.1
283
315
J98.9
ICD-10 Finland
Respiratory disorder, unspecified
111.2
130.4
142
13
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
5.9
130.2
384
678
H02AB07
ATC
prednisone; oral
2.3
129.2
1425
6949
J45.8
ICD-10 Finland
Mixed asthma
5.0
129.0
442
929
WX872
NOMESCO Finland
Intensive care
3.6
129.0
643
1919
R03DC03
ATC
montelukast; oral
2.4
127.2
1217
5525
348
Kela drug reimbursment
Roflumilast
32.6
124.8
166
52
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.0
123.1
1984
11362
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
122.7
1869
10466
J43.9
ICD-10 Finland
Emphysema, unspecified
6.5
122.4
335
536
E66.01
ICD-10 Finland
Obesity due to excess calories
3.5
119.8
615
1875
A02BC02
ATC
pantoprazole; systemic
1.7
119.1
4913
38312
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
6.5
117.8
323
518
J01FA06
ATC
roxithromycin; oral
1.8
117.5
3090
20941
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
5.2
116.4
379
752
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.0
115.6
730
2585
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.1
113.2
674
2291
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
112.1
2643
17223
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.0
111.9
1729
9683
R03AK08
ATC
formoterol and beclometasone; inhalant
4.5
111.2
421
980
N02AA05
ATC
oxycodone; systemic
2.1
110.1
1497
7952
ZXD05
NOMESCO Finland
Urgent procedure
1.8
109.6
2558
16582
R03DX07
ATC
roflumilast; oral
31.6
106.9
143
46
R03AC13
ATC
formoterol; inhalant
3.3
106.3
585
1876
J98.2
ICD-10 Finland
Interstitial emphysema
519.5
103.8
103
*
H02AB04
ATC
methylprednisolone; systemic
2.2
103.3
1274
6470
51998
ICD-8 Finland
Other diseases of respiratory system, Alii definiti
+∞
101.2
97
*
R03AC03
ATC
terbutaline; inhalant
2.2
99.5
1113
5400
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
14.3
98.6
171
122
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
97.2
1430
7797
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
96.8
2386
15595
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
94.3
1622
9373
51900
ICD-8 Finland
Other diseases of respiratory system, Atelectasis pulmonis
+∞
93.9
90
*
Z2446
NOMESCO Finland
Social worker
2.9
93.8
633
2329
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.9
92.9
632
2336
XG460
NOMESCO Finland
Short time oxymetry
5.1
92.6
307
620
G12.2
ICD-10 Finland
Motor neuron disease
12.5
91.8
169
138
SPAT1262
SPAT
Handing over of treatment supplies
1.9
90.2
1603
9356
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
88.6
1131
5793
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.5
88.2
443
1321
GBB00
NOMESCO Finland
Tracheostomy
6.8
88.2
231
348
N02AX02
ATC
tramadol; systemic, rectal
1.6
88.1
3301
24149
5180A
ICD-9 Finland
Other diseases of lung, Pulmonary collapse
+∞
87.6
84
*
E66.00
ICD-10 Finland
Metabolic syndrome
3.2
87.5
502
1652
J47
ICD-10 Finland
Bronchiectasis
5.0
86.7
290
592
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.4
86.6
446
1356
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.1
86.6
511
1716
A28
ICPC
Limited function/disability NOS
1.9
86.5
1551
9062
WX882
NOMESCO Finland
High dependency care
3.9
84.8
368
971
E66.9
ICD-10 Finland
Obesity, unspecified
4.4
83.2
317
741
A46
ICD-10 Finland
Erysipelas
2.0
83.2
1300
7209
J01FF01
ATC
clindamycin; systemic
1.7
82.7
2020
13036
B01AA03
ATC
warfarin; systemic
1.7
82.7
2196
14531
5198X
ICD-9 Finland
Other diseases of respiratory system, not elsewhere classified
+∞
82.4
79
*
N03AX16
ATC
pregabalin; oral
1.8
81.5
1758
10904
R03BA08
ATC
ciclesonide; inhalant
2.6
80.6
623
2483
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.1
80.2
476
1604
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
78.6
1116
5952
XW5WT
NOMESCO Finland
Other blood specimen with radiologicl guidance
26.9
78.4
109
41
1240
FHL
Bronchoscopy
5.7
78.1
234
420
E66.8
ICD-10 Finland
Other obesity
3.5
77.3
384
1134
XG467
NOMESCO Finland
Nocturnal CO2 monitoring
95.5
77.0
85
9
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
76.4
1217
6777
A06AD11
ATC
lactulose; oral
1.8
76.3
1509
9064
SPAT1254
SPAT
Administration of medicine
1.9
76.1
1326
7629
R04.2
ICD-10 Finland
Haemoptysis
3.2
76.1
433
1416
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
7.6
75.6
183
246
R06.2
ICD-10 Finland
Wheezing
3.2
75.1
422
1367
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.7
74.7
2088
13938
Z3226
NOMESCO Finland
Physiotherapist
1.8
74.3
1471
8832
I50.1
ICD-10 Finland
Left ventricular failure
2.5
73.5
624
2616
Z3231
NOMESCO Finland
Registered nurse
1.6
71.2
2154
14662
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.1
71.1
931
4787
5191A
ICD-9 Finland
Other diseases of respiratory system, Other diseases of trachea and bronchus, not elsewhere classified
+∞
70.9
68
*
N05CF01
ATC
zopiclone; oral
1.6
70.8
2630
18875
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
22.9
70.1
102
45
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.9
68.7
295
770
R03AC18
ATC
indacaterol; inhalant
7.8
68.4
163
214
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
68.1
1570
9860
Z3229
NOMESCO Finland
Other healthcare associate professional
2.2
68.0
801
3934
J01DB01
ATC
cefalexin; oral
1.6
67.8
5726
49537
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
5.7
67.4
201
359
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.8
67.0
461
1708
XG474
NOMESCO Finland
Exhalation nntrogen oxide
4.2
65.5
260
632
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
5.0
65.3
218
444
TKC20
NOMESCO Finland
Catheterisation of bladder
2.2
65.2
758
3695
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
3.9
64.2
274
712
J98.8
ICD-10 Finland
Other specified respiratory disorders
137.1
63.9
68
5
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.8
63.6
1217
7184
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.6
63.5
1936
13125
RK320
NOMESCO Finland
NA
7.0
63.4
162
236
L28
ICPC
Limited function/disability (L)
1.8
63.4
1392
8588
M04AA01
ATC
allopurinol; systemic
1.8
63.4
1306
7898
A02BC01
ATC
omeprazole; systemic
1.6
63.4
2194
15369
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
7.4
63.4
155
212
A41.9
ICD-10 Finland
Sepsis, unspecified
2.8
63.0
429
1578
N06AB04
ATC
citalopram; systemic
1.7
62.5
1524
9701
L04AA06
ATC
mycophenolic acid; systemic
5.5
62.5
191
352
ZX120
NOMESCO Finland
Intravenous
2.1
62.3
806
4111
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
5.9
62.1
181
315
R4110
NOMESCO Finland
Physiotherapy
1.6
62.0
1937
13202
Z51.5
ICD-10 Finland
Palliative care
2.3
61.9
616
2794
J45
ICD-10 Finland
Asthma
2.2
61.9
684
3257
N05BA01
ATC
diazepam; systemic, rectal
1.9
61.6
1047
5927
R03AK11
ATC
formoterol and fluticasone; inhalant
4.2
61.6
247
606
R60.0
ICD-10 Finland
Localized oedema
1.9
61.6
946
5162
XG405
NOMESCO Finland
Education on PEF monitoring
5.3
61.5
196
379
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.2
61.2
668
3163
R50.9
ICD-10 Finland
Fever, unspecified
1.8
61.2
1110
6427
J01CA04
ATC
amoxicillin; systemic
1.5
60.9
5461
47146
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
10.6
60.0
119
114
A07AA02
ATC
nystatin; oral
2.4
59.8
568
2517
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.4
59.3
308
941
5199X
ICD-9 Finland
Other diseases of respiratory system, Unspecified disease of respiratory system
+∞
58.4
56
*
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.5
58.0
2292
16503
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.5
57.2
475
1959
A10AE04
ATC
insulin glargine; parenteral
2.0
57.1
814
4309
I50
ICD-10 Finland
Heart failure
2.8
57.0
397
1480
GX2C5
NOMESCO Finland
Short-lasting oximetry
46.3
56.4
69
15
L04AX01
ATC
azathioprine; systemic
2.9
56.3
357
1252
N05AA02
ATC
levomepromazine; systemic
2.8
56.3
380
1389
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
4.4
56.2
211
486
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
4.8
55.9
193
408
M05BA04
ATC
alendronic acid; oral
2.1
55.6
717
3644
R96
ICPC
Asthma
2.2
55.6
638
3087
N06AX11
ATC
mirtazapine; oral
1.5
55.0
2122
15155
S97
ICPC
Chronic ulcer skin
2.3
54.8
530
2366
RK110
NOMESCO Finland
NA
6.7
54.1
141
212
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
53.8
854
4705
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
2.9
53.5
352
1266
N05BA04
ATC
oxazepam; oral
1.6
53.3
1744
11946
GX2D5
NOMESCO Finland
Sleep oximetry
16.7
53.3
86
52
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.5
52.9
2219
16127
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.9
52.9
332
1157
C01AA05
ATC
digoxin; systemic
1.8
52.6
994
5815
C01DA14
ATC
isosorbide mononitrate; oral
1.6
52.5
1715
11738
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.6
52.1
250
718
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
51.9
792
4296
JDB10
NOMESCO Finland
Percutaneous gastrostomy
4.6
51.6
184
403
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
51.4
1846
12919
GDG10
NOMESCO Finland
Bilateral transplantation of lung
38.5
51.3
65
17
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.7
51.2
1247
7881
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.1
50.8
301
1011
N05AH04
ATC
quetiapine; oral
1.8
50.7
1040
6239
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.3
50.6
522
2403
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
3.0
50.4
302
1021
127
Kela drug reimbursment
Transplant complication
5.4
50.2
156
294
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
49.9
1122
6921
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
49.5
1327
8604
A10BA02
ATC
metformin; oral
1.5
49.0
2219
16341
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.3
49.0
490
2220
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
48.9
675
3521
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
9.8
48.2
99
102
103
Kela drug reimbursment
Diabetes, insulin-treated
1.5
47.9
2181
16062
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.1
47.8
560
2730
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.0
47.8
642
3312
TK800
NOMESCO Finland
Hemodialysis
3.4
47.6
238
706
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.4
47.6
444
1945
WX781
NOMESCO Finland
Remote monitoring, noninvasive ventilation
470.4
47.3
47
*
AN1
HP
Coronary angiography
1.7
47.3
1107
6901
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.2
47.3
262
840
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
3.5
47.0
231
676
A02BC03
ATC
lansoprazole; oral
1.5
46.9
2146
15806
J95.0
ICD-10 Finland
Tracheostomy malfunction
+∞
46.9
45
*
Z94.2
ICD-10 Finland
Lung transplant status
23.3
46.6
67
29
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.7
46.5
1130
7119
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.0
46.2
620
3196
AA1AD
NOMESCO Finland
CT of head and brain
1.5
46.2
1879
13484
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
3.1
46.1
264
866
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.2
46.1
478
2203
J01DA01
ATC
[U] cefalexin; systemic
1.4
46.0
4397
37260
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.6
46.0
347
1356
J95.1
ICD-10 Finland
Acute pulmonary insufficiency following thoracic surgery
+∞
45.9
44
*
R4190
NOMESCO Finland
Nutritional therapy
3.1
45.8
265
876
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.1
45.8
572
2863
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
44.8
2952
23338
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
2.1
44.1
510
2466
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.5
44.1
2118
15723
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.0
44.0
578
2951
SPAT1060
SPAT
Administration of oxygen
8.5
43.7
97
115
J01MA02
ATC
ciprofloxacin; systemic
1.4
43.6
2917
23091
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
3.5
43.5
213
622
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.4
43.0
389
1678
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.4
43.0
402
1761
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.4
42.9
219
661
R03AL04
ATC
indacaterol and glycopyrronium bromide; inhalant
7.1
42.9
107
152
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
42.7
611
3225
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.1
42.6
526
2617
R13
ICD-10 Finland
Dysphagia
2.1
42.4
529
2641
R81
ICPC
Pneumonia
2.7
42.3
298
1118
A12BA01
ATC
potassium chloride; oral
2.1
42.2
523
2606
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.3
42.0
415
1869
N05CD07
ATC
temazepam; oral
1.6
41.9
1134
7340
GD2SN
NOMESCO Finland
Lung ventilation SPECT
6.3
41.9
114
183
A01AB09
ATC
miconazole; local oral
1.9
41.8
685
3799
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.2
41.7
443
2064
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
4.7
41.4
145
313
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.5
41.1
1724
12397
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
2.9
41.0
255
886
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.9
40.8
265
946
SPAT1229
SPAT
Assessment of need for aid
1.9
40.8
690
3868
R03DC01
ATC
zafirlukast; oral
4.0
40.7
169
430
C09AA05
ATC
ramipril; oral
1.5
40.7
2054
15350
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
40.5
1829
13359
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
4.3
40.3
153
358
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.6
40.3
316
1263
ZXE00
NOMESCO Finland
One hour or less
1.4
40.1
2686
21170
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.7
40.0
947
5901
N03AG01
ATC
valproic acid; systemic, rectal
2.2
39.6
406
1858
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
4.7
39.6
140
305
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
39.3
594
3200
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
7.9
39.2
91
116
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.9
38.8
580
3109
TJD20
NOMESCO Finland
Change of gastrostomy tube
9.2
38.7
82
90
ZX108
NOMESCO Finland
Inhalation
6.6
38.7
102
157
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.8
38.7
663
3734
GD1UN
NOMESCO Finland
Lung circulation SPECT
6.5
38.6
103
161
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.1
38.6
156
388
RS221
NOMESCO Finland
NA
4.3
38.3
147
348
UJF32
NOMESCO Finland
Coloscopy
1.5
38.3
1846
13639
SPAT1255
SPAT
Intravenous administration of medicine
2.0
38.2
527
2738
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.1
38.2
474
2363
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
3.7
38.1
175
486
J42
ICD-10 Finland
Unspecified chronic bronchitis
4.2
38.0
147
351
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
4.9
37.6
126
260
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
37.4
1177
7898
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.9
37.4
626
3495
SPAT1263
SPAT
Sampling
1.4
37.3
2830
22713
N06AX21
ATC
duloxetine; oral
1.9
37.2
602
3320
N02BE01
ATC
paracetamol; systemic, rectal
1.4
37.2
6044
55042
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
37.1
2173
16651
J01FA09
ATC
clarithromycin; systemic
1.5
37.1
1812
13405
WZC30
NOMESCO Finland
Teaching
1.7
37.1
890
5563
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.1
36.9
433
2108
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
4.5
36.7
134
302
JN4BD
NOMESCO Finland
Extensive body CT
1.7
36.6
838
5164
J95.5
ICD-10 Finland
Postprocedural subglottic stenosis
+∞
36.5
35
*
N02AA01
ATC
morphine; systemic, rectal
3.5
36.4
176
510
N07XX02
ATC
riluzole; oral
15.5
36.4
60
39
N03AX12
ATC
gabapentin; oral
1.6
36.3
988
6387
J61
ICD-10 Finland
Pneumoconiosis due to asbestos and other mineral fibres
4.6
36.2
129
284
WX704
NOMESCO Finland
Intubation
2.0
36.2
481
2465
Z43.0
ICD-10 Finland
Attention to tracheostomy
22.7
36.1
52
23
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.3
36.0
343
1517
J01FA10
ATC
azithromycin; systemic
1.4
36.0
3237
26680
N06AA09
ATC
amitriptyline; systemic
1.8
36.0
714
4213
WX726
NOMESCO Finland
High-flow oxygen therapy
25.1
35.7
50
20
B01AB05
ATC
enoxaparin; parenteral
1.4
35.7
2088
15970
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.7
35.7
728
4332
JN3AD
NOMESCO Finland
Abdominal CT examination
1.9
35.7
565
3091
A02BC05
ATC
esomeprazole; systemic
1.4
35.7
2616
20831
T90
ICPC
Diabetes non-insulin dependent
1.5
35.6
1664
12185
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
5.3
35.4
111
213
J43.8
ICD-10 Finland
Other emphysema
10.4
35.4
70
68
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.4
35.2
2043
15601
A02BA02
ATC
ranitidine; systemic
1.5
35.0
1530
11043
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
34.9
4456
38738
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.8
34.9
671
3917
N03AE01
ATC
clonazepam; systemic
2.1
34.9
409
1986
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.2
34.9
361
1661
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
4.3
34.7
131
306
R03BB02
ATC
oxitropium bromide; inhalant
4.3
34.3
130
305
WW200
NOMESCO Finland
Immunization
2.9
34.2
219
773
RK250
NOMESCO Finland
NA
7.6
34.0
81
108
N07BA03
ATC
varenicline; oral
2.5
34.0
279
1141
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
4.8
33.9
115
241
N06AX16
ATC
venlafaxine; oral
1.7
33.7
689
4099
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
33.6
1045
6979
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
33.5
1033
6883
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.2
33.5
356
1658
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.3
33.3
333
1509
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
3.3
33.3
172
526
R06AE07
ATC
cetirizine; oral
1.4
33.2
2463
19590
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
33.2
2178
16964
M10.9
ICD-10 Finland
Gout, unspecified
1.8
33.1
570
3210
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.6
33.1
253
995
D64.9
ICD-10 Finland
Anaemia, unspecified
1.6
33.1
889
5717
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.7
33.0
736
4493
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.4
33.0
1676
12450
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.8
33.0
221
805
UGC02
NOMESCO Finland
Rigid bronchoscopy
11.1
32.6
62
56
UGB02
NOMESCO Finland
Tracheoscopy
15.1
32.5
54
36
N05AH03
ATC
olanzapine; systemic
2.2
32.5
345
1607
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.8
32.5
546
3050
J95.2
ICD-10 Finland
Acute pulmonary insufficiency following nonthoracic surgery
+∞
32.3
31
*
R05
ICD-10 Finland
Cough
1.5
32.1
1233
8637
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
3.9
32.0
136
355
N05AF03
ATC
chlorprothixene; systemic
3.0
32.0
187
625
205
Kela drug reimbursment
Chronic hypertension
1.4
31.9
2452
19587
XG499
NOMESCO Finland
Other fysiological examination of respiatory function
9.8
31.9
65
67
XF600
NOMESCO Finland
Bloodpressure measurement
1.9
31.7
498
2716
RK310
NOMESCO Finland
NA
22.0
31.7
46
21
J86.9
ICD-10 Finland
Pyothorax without fistula
4.5
31.6
115
260
ZXE20
NOMESCO Finland
More than three and less than five hours
1.6
31.5
1012
6801
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.7
31.5
662
3970
R05
ICPC
Cough
1.5
31.4
1309
9331
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.2
31.3
349
1661
R03BB06
ATC
glycopyrronium bromide; inhalant
7.0
31.3
78
112
B90.9
ICD-10 Finland
Sequelae of respiratory and unspecified tuberculosis
5.5
31.2
94
173
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.0
31.2
402
2035
J01FA15
ATC
telithromycin; oral
1.8
30.9
574
3309
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
2.4
30.6
272
1161
J37.0
ICD-10 Finland
Chronic laryngitis
2.6
30.6
235
930
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.3
30.6
300
1346
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
30.4
2064
16123
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
30.3
2616
21243
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.0
30.2
418
2173
J95.9
ICD-10 Finland
Postprocedural respiratory disorder, unspecified
+∞
30.2
29
*
R94.2
ICD-10 Finland
Abnormal results of pulmonary function studies
6.0
30.2
84
140
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.8
29.9
203
747
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
3.0
29.8
183
629
R99
ICPC
Respiratory disease other
3.2
29.8
159
499
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.2
29.5
301
1377
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
29.4
1124
7854
A10AE05
ATC
insulin detemir; parenteral
2.0
29.4
410
2139
SPAT1231
SPAT
Assessment of adjustments needed in living environment
2.6
29.2
215
829
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.0
29.2
408
2131
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
29.1
2133
16847
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
5.0
28.9
95
193
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.1
28.9
331
1595
R03AC19
ATC
olodaterol; inhalant
7.6
28.9
68
90
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.2
28.7
291
1328
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.7
28.6
571
3366
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.6
28.6
213
829
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
28.6
1828
14103
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.4
28.6
1675
12727
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.2
28.6
314
1483
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
29.3
28.4
38
13
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.6
28.3
706
4442
F20.9
ICD-10 Finland
Schizophrenia, unspecified
3.4
28.3
142
426
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
3.4
28.2
138
406
4912A
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]
4.4
28.1
103
235
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
5.6
28.0
83
150
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.0
28.0
371
1895
TQW11
NOMESCO Finland
Vacuum treatment of wound
3.1
28.0
161
533
GBB13
NOMESCO Finland
Revision of tracheostomy
16.2
27.9
45
28
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.1
27.9
324
1569
N05BA12
ATC
alprazolam; oral
1.7
27.9
618
3762
N05BA06
ATC
lorazepam; systemic, sublingual
1.9
27.9
401
2115
J92.9
ICD-10 Finland
Pleural plaque without asbestos
3.3
27.8
141
426
284
Kela drug reimbursment
Nintedanib and pirfenidone
6.7
27.8
71
106
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.7
27.4
188
694
TGA30
NOMESCO Finland
Thoracocentesis
4.2
27.3
105
251
49300
ICD-8 Finland
Asthma, bronchiale
2.6
27.0
203
794
R53
ICD-10 Finland
Malaise and fatigue
1.4
27.0
1409
10464
R29
ICPC
Respiratory symptom/complaint other
1.9
26.9
387
2041
RD210
NOMESCO Finland
NA
3.2
26.8
145
460
T82
ICPC
Obesity
2.6
26.6
196
758
RS220
NOMESCO Finland
NA
3.8
26.6
116
311
R05CB01
ATC
acetylcysteine; inhalant, oral
2.7
26.5
183
680
C08DA01
ATC
verapamil; systemic
2.0
26.5
354
1817
P01AB01
ATC
metronidazole; oral, rectal
1.3
26.4
2271
18333
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.3
26.4
243
1060
A10BH01
ATC
sitagliptin; oral
1.6
26.4
693
4420
A10BB12
ATC
glimepiride; oral
1.6
26.3
661
4163
N99
ICPC
Neurological disease other
3.8
26.3
113
299
I25.2
ICD-10 Finland
Old myocardial infarction
1.6
26.3
708
4544
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.0
26.2
359
1860
Z93.0
ICD-10 Finland
Tracheostomy status
36.8
26.1
33
9
51928
ICD-8 Finland
Other diseases of respiratory system, Morbi pulmonum alii
+∞
26.0
25
*
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.8
25.9
458
2597
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.0
25.9
342
1747
I27.0
ICD-10 Finland
Primary pulmonary hypertension
10.3
25.9
51
50
J41.1
ICD-10 Finland
Mucopurulent chronic bronchitis
6.1
25.9
71
117
L04AD01
ATC
ciclosporin; systemic
3.3
25.8
134
413
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
3.2
25.8
138
435
SPAT1301
SPAT
No procedures
1.3
25.8
2143
17201
XA421
NOMESCO Finland
Nocturnal polygraphy
8.5
25.6
56
66
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
2.1
25.6
298
1447
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
3.4
25.5
127
380
E000001
ATC
NA
1.4
25.4
1251
9182
N06AB03
ATC
fluoxetine; oral
1.6
25.3
701
4530
R05FB02
ATC
cough suppressants and expectorants
1.3
25.3
2595
21466
H02AB09
ATC
hydrocortisone; systemic
2.8
25.3
165
595
N03AX09
ATC
lamotrigine; oral
2.4
25.2
228
983
SPAT1234
SPAT
Support of social functional capacity
1.9
25.2
414
2291
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
2.5
25.1
208
859
J15.8
ICD-10 Finland
Other bacterial pneumonia
4.5
25.1
91
206
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
4.9
25.1
83
171
SPAT1059
SPAT
Spirometry at the office
1.9
25.0
360
1898
J94.8
ICD-10 Finland
Other specified pleural conditions
2.7
24.9
169
623
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.3
24.9
230
1006
N05AX12
ATC
aripiprazole; systemic
2.8
24.8
164
593
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.7
24.8
517
3087
356
Kela drug reimbursment
Nintedanib and pirfenidone
6.9
24.8
62
90
Z2221
NOMESCO Finland
Medical doctor
1.4
24.8
1751
13682
J01DA06
ATC
[U] cefuroxime; systemic
1.5
24.7
905
6248
JN4AD
NOMESCO Finland
Body CT examination
1.7
24.7
541
3281
Z99.1
ICD-10 Finland
Dependence on respirator
250.9
24.7
25
*
R03BB07
ATC
umeclidinium bromide; inhalant
4.7
24.7
85
183
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
4.0
24.6
99
248
A03
ICPC
Fever
1.6
24.6
775
5170
C08CA01
ATC
amlodipine; oral
1.3
24.6
2637
21927
F29
ICD-10 Finland
Unspecified nonorganic psychosis
2.6
24.5
179
689
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.4
24.5
210
884
E87.6
ICD-10 Finland
Hypokalaemia
2.3
24.5
226
985
Q32.21
ICD-10 Finland
Secondary congenital bronchomalacia
12.3
24.4
44
36
J20
ICD-10 Finland
Acute bronchitis
1.7
24.4
565
3479
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.0
24.3
315
1595
N05AH02
ATC
clozapine; systemic
3.8
24.3
106
285
N07BB01
ATC
disulfiram; oral
2.2
24.3
242
1097
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.2
24.2
264
1246
ZXE10
NOMESCO Finland
More than one and less than three hours
1.3
24.1
2422
19937
XF622
NOMESCO Finland
Measurement of minute volume of heart
7.1
24.0
59
84
J95.8
ICD-10 Finland
Other postprocedural respiratory disorders
+∞
24.0
23
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
23.9
540
3304
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.9
23.8
388
2142
TGB20
NOMESCO Finland
Tracheostomy tube replacement
20.7
23.8
35
17
Q32.0
ICD-10 Finland
Congenital tracheomalacia
20.7
23.8
35
17
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.4
23.8
1164
8519
A04
ICPC
Weakness/tiredness general
1.5
23.7
851
5846
E0000UV
ATC
NA
1.3
23.7
2350
19306
R47.1
ICD-10 Finland
Dysarthria and anarthria
3.8
23.6
101
267
XV5WT
NOMESCO Finland
NA
125.3
23.6
25
*
ZY010
NOMESCO Finland
Hospital outpatient
2.2
23.6
249
1157
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
23.4
1912
15261
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
3.0
23.4
141
483
K77
ICPC
Heart failure
2.4
23.3
205
876
E87.5
ICD-10 Finland
Hyperkalaemia
2.6
23.2
171
663
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
3.7
23.1
102
277
R33
ICD-10 Finland
Retention of urine
1.5
23.1
732
4884
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.0
23.0
312
1612
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
3.5
23.0
108
309
RK323
NOMESCO Finland
NA
8.5
23.0
50
59
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.4
22.8
196
828
N06AX03
ATC
mianserin; oral
1.9
22.7
328
1735
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.8
22.7
151
550
N18.8
ICD-10 Finland
Other chronic renal failure
2.1
22.6
253
1209
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
5.1
22.6
72
143
RS230
NOMESCO Finland
NA
6.1
22.4
61
100
K07
ICPC
Swollen ankles/oedema
1.9
22.4
335
1796
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.5
22.2
175
702
F10.20
ICD-10 Finland
Alcohol dependence currently independent
3.0
22.2
134
459
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
1.7
22.1
519
3205
N06AB06
ATC
sertraline; oral
1.6
22.1
535
3333
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.1
22.1
262
1281
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.4
22.0
1198
8932
F34.1
ICD-10 Finland
Dysthymia
2.5
22.0
181
746
R60.9
ICD-10 Finland
Oedema, unspecified
1.9
22.0
330
1770
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
2.6
22.0
163
634
GBB96
NOMESCO Finland
Other tracheostomy procedure
15.0
21.9
36
24
F61.0
ICD-10 Finland
Mixed personality disorders
3.7
21.9
96
260
J01XX08
ATC
linezolid; systemic
5.5
21.9
65
119
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
5.1
21.8
69
136
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
4.5
21.8
77
171
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
21.7
1923
15500
TK810
NOMESCO Finland
Hemofiltration
4.7
21.7
74
158
A11CC03
ATC
alfacalcidol; systemic
2.4
21.7
194
836
Z49.1
ICD-10 Finland
Extracorporeal dialysis
3.0
21.6
125
417
5CM18
NOMESCO Finland
NA
5.6
21.6
63
113
SPAT1211
SPAT
Application of soft bandage
1.6
21.6
579
3708
RF220
NOMESCO Finland
NA
2.9
21.5
131
453
XF614
NOMESCO Finland
Measurement of pulmonary artery pressure
8.7
21.5
46
53
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
9.0
21.5
45
50
ZXA10
NOMESCO Finland
Bilateral
1.4
21.5
1260
9516
A03FA01
ATC
metoclopramide; systemic, rectal
1.4
21.4
1265
9567
XX4BW
NOMESCO Finland
NA
10.6
21.3
41
39
R06.8
ICD-10 Finland
Other and unspecified abnormalities of breathing
3.1
21.2
119
390
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
7.2
21.1
51
71
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.7
21.1
417
2450
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
21.1
994
7211
R04
ICPC
Breathing problem other
2.2
21.1
217
998
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
3.4
20.9
104
312
I46.0
ICD-10 Finland
Cardiac arrest with successful resuscitation
2.6
20.8
154
600
L04AX05
ATC
pirfenidone; oral
7.5
20.8
49
66
R05FA02
ATC
opium derivatives and expectorants; systemic
1.3
20.8
2490
20890
I20.00
ICD-10 Finland
Unstable angina
1.9
20.8
306
1631
A31.0
ICD-10 Finland
Pulmonary mycobacterial infection
6.5
20.7
54
84
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.3
20.7
196
869
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
4.7
20.7
70
149
GBA32
NOMESCO Finland
Endoscopic dilatation of trachea
110.3
20.6
22
*
R11
ICD-10 Finland
Nausea and vomiting
1.6
20.4
503
3149
ZZA00
NOMESCO Finland
Split skin graft
2.1
20.4
236
1144
WX900
NOMESCO Finland
Resuscitation
4.7
20.2
69
148
R03BB05
ATC
aclidinium bromide; inhalant
6.9
20.1
50
73
R03AL05
ATC
formoterol and aclidinium bromide; inhalant
6.9
20.1
50
73
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
2.9
20.0
121
415
A10BJ02
ATC
liraglutide; parenteral
2.6
20.0
147
568
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.3
19.9
182
792
C07AB02
ATC
metoprolol; systemic
1.3
19.9
1713
13724
R04.0
ICD-10 Finland
Epistaxis
1.6
19.9
545
3508
FWC00
NOMESCO Finland
Reoperation for deep infection in surgery of heart and major thoracic vessels
12.5
19.8
35
28
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
4.7
19.8
67
143
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.7
19.7
443
2703
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.7
19.7
454
2789
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
2.3
19.7
191
855
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
2.7
19.6
138
523
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
4.9
19.5
64
132
N06AB10
ATC
escitalopram; oral
1.4
19.5
940
6842
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.8
19.5
129
471
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
3.5
19.4
90
256
SPAT1216
SPAT
Assessment of functional ability
1.4
19.4
1131
8517
J02AC01
ATC
fluconazole; systemic
1.3
19.4
1922
15693
I20.09
ICD-10 Finland
Unstable angina
1.6
19.4
481
3017
R4130
NOMESCO Finland
Speech therapy
2.4
19.4
167
705
SPAT1251
SPAT
Organisation of medication
1.9
19.4
299
1622
P99
ICPC
Psychological disorders other
2.8
19.3
127
461
J43.2
ICD-10 Finland
Centrilobular emphysema
6.1
19.3
52
85
WX002
NOMESCO Finland
Sedation and analgesia
1.4
19.1
1260
9683
Z72.0
ICD-10 Finland
Tobacco use
2.6
19.1
143
562
B01AC04
ATC
clopidogrel; oral
1.4
19.1
1233
9450
N17.8
ICD-10 Finland
Other acute renal failure
3.1
19.0
103
330
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
19.0
2243
18733
SPAT1215
SPAT
Assessment of need for medical rehabilitation
1.9
18.9
279
1488
J43.1
ICD-10 Finland
Panlobular emphysema
14.8
18.9
31
21
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.4
18.8
835
5985
R05CB03
ATC
carbocisteine; oral
2.2
18.8
183
824
K59.09
ICD-10 Finland
Constipation, unspecified
1.7
18.7
429
2634
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.7
18.6
412
2505
E66.0
ICD-10 Finland
Obesity due to excess calories
3.5
18.6
86
245
GX1P5
NOMESCO Finland
Nocturnal CO2 monitoring
100.2
18.5
20
*
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.2
18.5
196
914
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
18.5
715
4981
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
18.4
1448
11428
J80
ICD-10 Finland
Adult respiratory distress syndrome
5.5
18.3
54
99
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
2.7
18.3
129
488
N05BA02
ATC
chlordiazepoxide; systemic
2.3
18.3
172
762
XX2XT
NOMESCO Finland
Other injection with other radiological guidance
6.3
18.3
48
76
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.4
18.3
859
6220
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.5
18.3
199
3569
WX723
NOMESCO Finland
CPAP therapy
2.2
18.2
185
849
XQ800
NOMESCO Finland
Prick test
1.8
18.2
323
1837
E66
ICD-10 Finland
Obesity
2.1
18.2
199
942
C02KX04
ATC
macitentan; oral
25.0
18.2
25
10
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.4
18.2
928
6826
WYA20
NOMESCO Finland
Home visit
2.4
18.2
153
641
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.7
18.1
414
2540
Z02.4
ICD-10 Finland
Examination for driving licence
0.7
18.1
1100
14049
I26
ICD-10 Finland
Pulmonary embolism
3.7
18.1
79
215
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
18.1
2098
17459
A98
ICPC
Health maint/preventive medicine
0.8
18.0
5655
60103
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
4.7
18.0
61
131
A02BA04
ATC
nizatidine; systemic
1.5
17.8
580
3890
Z02.7
ICD-10 Finland
Issue of medical certificate
1.7
17.8
372
2222
R1250
NOMESCO Finland
Evaluation of functional capability
2.4
17.8
147
607
G72.9
ICD-10 Finland
Myopathy, unspecified
3.8
17.8
75
198
310
Kela drug reimbursment
Orlistat, sibutramine and other major and expensive medicines used to treat obesity
3.2
17.8
94
297
A41.8
ICD-10 Finland
Other specified sepsis
2.5
17.7
143
584
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.4
17.7
156
669
RS222
NOMESCO Finland
NA
3.0
17.6
102
342
E87.2
ICD-10 Finland
Acidosis
4.7
17.6
59
125
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
6.0
17.6
48
80
M05BA07
ATC
risedronic acid; oral
2.0
17.6
220
1103
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.2
17.6
188
884
N19
ICD-10 Finland
Unspecified kidney failure
1.8
17.5
289
1605
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.6
17.4
428
2675
N02AC04
ATC
dextropropoxyphene; oral
1.7
17.4
334
1947
C10AA01
ATC
simvastatin; oral
1.2
17.4
3328
29316
RF120
NOMESCO Finland
NA
3.1
17.4
94
302
I42.0
ICD-10 Finland
Dilated cardiomyopathy
2.0
17.3
220
1109
SPAT1240
SPAT
Therapeutic discussion
1.6
17.2
430
2703
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
1.8
17.1
281
1557
160
Kela drug reimbursment
exenatide
2.6
17.1
129
509
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.5
16.9
562
3786
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
3.9
16.9
69
178
M79.6
ICD-10 Finland
Pain in limb
1.3
16.9
2047
17101
A01AB04
ATC
amphotericin B; local oral
1.7
16.8
342
2030
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
1.9
16.8
251
1345
N06AA06
ATC
trimipramine; systemic
2.3
16.8
153
668
J12.8
ICD-10 Finland
Other viral pneumonia
3.8
16.7
70
184
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
2.3
16.7
149
641
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
2.9
16.7
103
361
GCA18
NOMESCO Finland
Bronchoscopic dilatation of bronchus
63.4
16.7
19
*
J84.0
ICD-10 Finland
Alveolar and parietoalveolar conditions
11.1
16.7
31
28
51994
ICD-8 Finland
Other diseases of respiratory system, Insufficientia respirationis
+∞
16.7
16
*
RF210
NOMESCO Finland
NA
2.2
16.6
166
758
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.7
16.6
367
2229
R06.5
ICD-10 Finland
Mouth breathing
1.6
16.6
468
3033
N05AC02
ATC
thioridazine; oral
2.5
16.6
130
525
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
4.6
16.5
57
125
N06AA12
ATC
doxepin; systemic
1.7
16.5
353
2126
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
7.0
16.5
40
57
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
3.9
16.5
67
172
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.4
16.4
708
5041
48609
ICD-8 Finland
Pneumonia, unspecified
2.8
16.4
105
376
D86.0
ICD-10 Finland
Sarcoidosis of lung
3.1
16.4
90
293
5826
FHL
Lobectomy or bilobectomy
6.5
16.4
42
65
RS121
NOMESCO Finland
NA
4.2
16.3
62
150
3472A
ICD-9 Finland
Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]
2.4
16.3
137
573
B01AF02
ATC
apixaban; oral
1.4
16.3
700
4981
Z94.0
ICD-10 Finland
Kidney transplant status
3.4
16.3
78
230
R01AD09
ATC
mometasone; nasal
1.2
16.2
2320
19743
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.1
16.2
177
839
M03BX01
ATC
baclofen; systemic
2.7
16.1
112
421
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.3
16.1
154
690
J01GB01
ATC
tobramycin; inhalant, parenteral
24.5
16.0
22
9
I20.90
ICD-10 Finland
Angina pectoris, unspecified
1.7
16.0
327
1946
49104
ICD-8 Finland
Chronic bronchitis, Cum emphysemate
4.3
15.9
59
139
J38.6
ICD-10 Finland
Stenosis of larynx
21.0
15.9
23
11
XF404
NOMESCO Finland
Ambulatory ECG
1.5
15.9
622
4342
1350A
ICD-9 Finland
Sarcoidosis[SARCOIDOSIS]
6.2
15.8
42
68
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
2.1
15.8
182
884
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
5.2
15.8
48
92
WW500
NOMESCO Finland
Blood transfusion
1.8
15.8
266
1488
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.8
15.8
264
1473
J01EA01
ATC
trimethoprim; systemic
1.3
15.7
1520
12316
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.3
15.7
1678
13774
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.5
15.7
588
4065
C02KX05
ATC
riociguat; oral
33.4
15.7
20
6
RF420
NOMESCO Finland
NA
2.9
15.7
94
325
R52.2
ICD-10 Finland
Other chronic pain
2.1
15.7
185
905
K08.3
ICD-10 Finland
Retained dental root
1.6
15.7
421
2698
N04AA02
ATC
biperiden; systemic
2.5
15.6
127
523
D75.1
ICD-10 Finland
Secondary polycythaemia
4.2
15.6
59
142
J81
ICD-10 Finland
Pulmonary oedema
3.4
15.6
75
222
G82.2
ICD-10 Finland
Paraplegia, unspecified
4.9
15.6
50
102
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
15.6
858
6389
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
2.0
15.6
211
1094
I95.9
ICD-10 Finland
Hypotension, unspecified
2.5
15.5
124
508
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.8
15.5
1426
17327
B01AB10
ATC
tinzaparin; parenteral
1.6
15.5
416
2666
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.6
15.5
395
2495
R03DA54
ATC
theophylline, combinations excl. psycholeptics; systemic
2.5
15.5
121
490
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.0
15.5
204
1048
J01CE08
ATC
benzathine benzylpenicillin; parenteral
3.0
15.4
88
293
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
1.8
15.4
275
1569
N03AF01
ATC
carbamazepine; oral, rectal
1.7
15.3
348
2133
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
3.4
15.3
72
210
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.5
15.2
121
492
132
Kela drug reimbursment
Sarcoidosis
3.9
15.2
62
160
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
1.8
15.2
257
1438
J93.0
ICD-10 Finland
Spontaneous tension pneumothorax
6.7
15.2
38
57
L01XE31
ATC
[U] nintedanib; oral
8.3
15.2
33
40
C08DB01
ATC
diltiazem; oral
1.5
15.2
481
3207
RF410
NOMESCO Finland
NA
3.1
15.2
82
265
I45.9
ICD-10 Finland
Conduction disorder, unspecified
3.0
15.1
88
298
A10BJ06
ATC
semaglutide; parenteral
2.1
15.1
165
784
R78
ICPC
Acute bronchitis/bronchiolitis
2.3
15.1
142
631
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.8
15.1
273
1566
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
2.4
15.1
123
507
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
5.2
15.1
46
89
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
2.6
15.0
106
404
Z08
ICPC
Social welfare problem
3.1
15.0
81
261
J69.1
ICD-10 Finland
Pneumonitis due to oils and essences
45.0
15.0
18
*
GDA10
NOMESCO Finland
Biopsy of lung
6.6
15.0
38
58
N05AA01
ATC
chlorpromazine; systemic, rectal
2.9
15.0
90
312
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.6
15.0
393
2504
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
14.9
1743
14455
N05AB03
ATC
perphenazine; systemic, rectal
2.0
14.9
197
1010
5AB14
NOMESCO Finland
NA
9.4
14.9
30
32
Z93.1
ICD-10 Finland
Gastrostomy status
15.0
14.8
24
16
C03AA03
ATC
hydrochlorothiazide; oral
1.4
14.8
687
4961
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
2.7
14.8
98
362
I21.99
ICD-10 Finland
Myocardial infarction (acute) UNS unspecified coronary artery status
1.8
14.8
263
1501
C09AA02
ATC
enalapril; systemic
1.3
14.8
1539
12582
01107
ICD-8 Finland
Pulmonary tuberculosis, Suspecta
5.8
14.7
41
71
R07.3
ICD-10 Finland
Other chest pain
1.5
14.7
561
3893
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
1.8
14.7
247
1382
N06AA10
ATC
nortriptyline; systemic
2.5
14.6
117
479
L04AA01
ATC
[U] ciclosporin; systemic
2.8
14.6
95
346
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.1
14.6
158
747
207
Kela drug reimbursment
Chronic arrhythmias
1.3
14.5
1138
8950
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
6.3
14.5
38
61
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.6
14.5
386
2469
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.0
14.5
192
989
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
4.5
14.4
50
111
SPAT1260
SPAT
Consultation of another employee
1.3
14.4
1069
8341
A01
ICPC
Pain general/multiple sites
1.5
14.4
443
2933
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
2.4
14.3
116
479
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.5
14.3
459
3069
4931B
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]
3.9
14.3
57
145
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.6
14.2
342
2129
Z71.8
ICD-10 Finland
Other specified counselling
1.3
14.2
1212
9643
UJC01
NOMESCO Finland
Scopy of lower throat
3.0
14.2
82
276
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.6
14.2
388
2497
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
2.2
14.2
140
635
J15.1
ICD-10 Finland
Pneumonia due to Pseudomonas
10.4
14.2
27
26
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
10.4
14.2
27
26
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.7
14.2
318
1944
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.4
14.1
603
4279
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
3.3
14.1
71
218
N06DA02
ATC
donepezil; oral
0.6
14.1
194
3274
JAH00
NOMESCO Finland
Laparotomy
1.9
14.1
195
1020
SPAT1245
SPAT
Provision of support and information to patient’s family members
1.6
14.1
339
2113
T59.7
ICD-10 Finland
Toxic effect: Carbon dioxide
42.5
14.1
17
*
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
2.2
14.1
147
685
R03BC03
ATC
nedocromil; inhalant
1.6
14.0
375
2399
SPAT1252
SPAT
Overall medication plan or its review
1.5
14.0
482
3271
J18.8
ICD-10 Finland
Other pneumonia, organism unspecified
4.5
14.0
49
110
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
3.5
14.0
64
183
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
3.9
14.0
56
143
N28
ICPC
Limited function/disability (N)
2.4
14.0
117
492
ZX114
NOMESCO Finland
Intramuscular
2.7
14.0
96
362
JN4CD
NOMESCO Finland
Very extensive body CT
1.7
13.9
264
1534
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.0
13.9
170
847
Z00.0
ICD-10 Finland
General medical examination
1.3
13.9
1098
8638
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
1.6
13.8
331
2057
S22.3
ICD-10 Finland
Fracture of rib
1.5
13.8
420
2775
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
2.9
13.8
85
299
J01FA01
ATC
erythromycin; systemic
1.4
13.8
646
4668
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.0
13.8
178
909
N05AF05
ATC
zuclopenthixol; systemic
3.4
13.8
66
196
S76
ICPC
Skin infection other
1.7
13.7
302
1834
J02AC03
ATC
voriconazole; systemic
8.1
13.7
30
37
H26.3
ICD-10 Finland
Drug-induced cataract
4.5
13.7
48
108
R03DA05
ATC
aminophylline; systemic, rectal
2.8
13.7
86
308
F10.25
ICD-10 Finland
Alcohol dependence continuous use
2.6
13.6
99
387
J18
ICD-10 Finland
Pneumonia, organism unspecified
3.2
13.6
69
214
UJD02
NOMESCO Finland
Gastroscopy
1.6
13.6
329
2055
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
2.3
13.6
123
538
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.1
13.6
151
724
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
1.6
13.6
320
1982
51993
ICD-8 Finland
Other diseases of respiratory system, Stenosis bronchi et tracheae
+∞
13.5
13
*
5194A
ICD-9 Finland
Other diseases of respiratory system, Disorders of diaphragm
+∞
13.5
13
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.7
13.5
308
1889
OAB43
SPAT
NA
0.6
13.5
180
3061
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
2.9
13.5
79
270
N02AJ06
ATC
codeine and paracetamol; systemic
1.2
13.5
2003
17046
R40.2
ICD-10 Finland
Coma, unspecified
2.9
13.5
83
291
UDQ02
NOMESCO Finland
Direct laryngoscopy
3.4
13.5
65
194
49099
ICD-8 Finland
Bronchitis, unspecified
2.8
13.5
84
299
J04AB02
ATC
rifampicin; systemic
2.6
13.5
96
369
B03XA02
ATC
darbepoetin alfa; parenteral
2.2
13.5
136
627
N30.0
ICD-10 Finland
Acute cystitis
1.4
13.4
770
5764
NHQ40
NOMESCO Finland
Amputation of toe
2.1
13.4
146
695
R06.1
ICD-10 Finland
Stridor
5.1
13.4
41
80
A07AA09
ATC
vancomycin; oral
2.6
13.4
99
388
WX890
NOMESCO Finland
Intesive care monitoring
2.9
13.3
78
268
N03AF02
ATC
oxcarbazepine; oral
1.9
13.2
182
951
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
3.3
13.2
65
197
E000006
ATC
NA
1.5
13.2
395
2598
M09AA72
ATC
quinine, combinations with psycholeptics; systemic
1.7
13.2
290
1765
A08AB01
ATC
orlistat; oral
3.3
13.1
65
198
XFE00
NOMESCO Finland
Epicardial ultrasonography
1.9
13.1
193
1031
R03AL11
ATC
formoterol, glycopyrronium bromide and budesonide; inhalant
40.1
13.1
16
*
XG416
NOMESCO Finland
Measurement of maximal airway pressure
40.1
13.1
16
*
SPAT1172
SPAT
Guidance concerning hydration
1.9
13.1
183
961
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.8
13.1
224
1262
SPAT1325
SPAT
Vaccination
1.2
13.1
2309
19993
51899
ICD-8 Finland
Bronchiectasis
5.3
13.1
39
74
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.5
13.1
392
2581
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.4
13.1
617
4467
TQW80
NOMESCO Finland
Local dermatologic skincare
2.0
13.0
165
835
UKC02
NOMESCO Finland
Cystoscopy
1.3
13.0
1271
10289
K59.1
ICD-10 Finland
Functional diarrhoea
1.7
13.0
293
1794
K59.0
ICD-10 Finland
Constipation
1.6
13.0
379
2481
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
2.7
13.0
89
335
C02KX01
ATC
bosentan; oral
16.7
12.9
20
12
K92.1
ICD-10 Finland
Melaena
1.5
12.9
386
2538
GD1RA
NOMESCO Finland
Dynamic X-ray examination of respiratory organs with convetional X-ray picture
8.7
12.9
27
31
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
12.9
182
961
UJC12
NOMESCO Finland
Flexible oesophagoscopy
3.3
12.9
63
190
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
12.9
1483
12248
GD1FN
NOMESCO Finland
Lung ventilation isotope imaging
19.0
12.9
19
10
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.5
12.9
442
3001
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
3.0
12.9
72
240
K56.0
ICD-10 Finland
Paralytic ileus
2.7
12.8
88
330
49109
ICD-8 Finland
Chronic bronchitis, Unspecified
4.4
12.8
45
102
G40.9
ICD-10 Finland
Epilepsy, unspecified
1.8
12.8
218
1229
GAA31
NOMESCO Finland
Thoracoscopy
4.7
12.8
42
89
SPAT1257
SPAT
Teaching of medicine inhalation technique
1.8
12.8
212
1185
E86
ICD-10 Finland
Volume depletion
1.9
12.7
194
1052
V03AE01
ATC
polystyrene sulfonate; oral
2.4
12.7
108
456
J93.9
ICD-10 Finland
Pneumothorax, unspecified
3.6
12.7
56
156
EBA10
NOMESCO Finland
Surgical removal of tooth
1.5
12.7
483
3354
B44.1
ICD-10 Finland
Other pulmonary aspergillosis
9.6
12.7
25
26
P76
ICPC
Depressive disorder
1.8
12.7
218
1231
U04
ICPC
Incontinence urine
1.6
12.6
301
1873
48509
ICD-8 Finland
Bronchopneumonia, unspecified
2.9
12.6
76
266
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.6
12.6
309
1936
SPAT1058
SPAT
PEF monitoring instruction
1.5
12.6
449
3074
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.4
12.6
538
3821
M10.0
ICD-10 Finland
Idiopathic gout
1.8
12.6
230
1324
V03AA01
ATC
NA
2.3
12.6
110
473
M48.0
ICD-10 Finland
Spinal stenosis
1.3
12.6
804
6128
K93
ICPC
Pulmonary embolism
2.8
12.6
80
290
M05BB03
ATC
alendronic acid and colecalciferol; oral
2.0
12.5
159
804
F60.9
ICD-10 Finland
Personality disorder, unspecified
3.3
12.5
61
184
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.2
12.5
126
578
RS122
NOMESCO Finland
NA
7.0
12.5
30
43
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.3
12.5
973
7639
E000003
ATC
NA
1.7
12.4
250
1481
J95.3
ICD-10 Finland
Chronic pulmonary insufficiency following surgery
130.1
12.4
13
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
3.1
12.4
67
218
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.5
12.4
459
3166
R51.80
ICD-10 Finland
Headache
1.4
12.4
662
4898
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.6
12.3
347
2250
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
2.8
12.3
79
288
ZXD00
NOMESCO Finland
Emergency procedure
1.8
12.3
211
1192
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
3.0
12.3
71
241
J12.9
ICD-10 Finland
Viral pneumonia, unspecified
4.0
12.3
48
121
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.4
12.3
583
4225
P72
ICPC
Schizophrenia
2.6
12.3
86
330
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
3.2
12.2
62
193
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
1.8
12.2
207
1164
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
3.0
12.2
70
235
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
1.5
12.2
373
2468
Q32.20
ICD-10 Finland
Congenital bronchomalacia
37.6
12.2
15
*
RS123
NOMESCO Finland
NA
9.6
12.2
24
25
WNF00
NOMESCO Finland
Infection source and contact determination
4.0
12.2
47
117
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
1.9
12.2
181
973
6BA02
NOMESCO Finland
NA
6.7
12.2
30
45
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
6.7
12.2
30
45
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
2.1
12.1
133
634
XA420
NOMESCO Finland
Extensive sleep examination
2.8
12.1
77
279
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
2.3
12.1
110
484
Z50.1
ICD-10 Finland
Other physical therapy
1.6
12.1
319
2037
P03
ICPC
Feeling depressed
1.6
12.1
316
2015
P15
ICPC
Chronic alcohol abuse
2.1
12.1
128
603
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
3.7
12.0
52
143
4919X
ICD-9 Finland
Chronic bronchitis, Unspecified chronic bronchitis
5.4
12.0
35
65
GBB18
NOMESCO Finland
Closure of tracheostomy
18.0
12.0
18
10
M41.4
ICD-10 Finland
Neuromuscular scoliosis
18.0
12.0
18
10
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.3
12.0
940
7381
E88.0
ICD-10 Finland
Disorders of plasma-protein metabolism, not elsewhere classified
8.6
12.0
25
29
N05AX08
ATC
risperidone; systemic
1.4
12.0
528
3772
D07AB02
ATC
hydrocortisone butyrate; topical
1.2
11.9
1619
13615
F10.09
ICD-10 Finland
Alcohol intoxication UNS
2.3
11.9
109
480
N06DX01
ATC
memantine; oral
0.6
11.9
254
3885
R5599
NOMESCO Finland
Other rehabilitation service
1.9
11.9
163
851
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
2.0
11.9
150
759
-69
ICPC
Other reason for encounter NEC
1.7
11.9
238
1409
XF640
NOMESCO Finland
NA
1.8
11.9
211
1205
P29
ICPC
Psychological sympt/compl other
1.8
11.9
202
1140
Z49.2
ICD-10 Finland
Other dialysis
3.6
11.9
52
145
XA402
NOMESCO Finland
ENMG
2.1
11.8
136
664
G56.2
ICD-10 Finland
Lesion of ulnar nerve
1.9
11.8
160
834
318
Kela drug reimbursment
Teriparatide
4.0
11.8
46
116
GDC00
NOMESCO Finland
Lobectomy of lung
3.1
11.8
64
210
-50
ICPC
Medication/prescr/renewal
1.6
11.8
269
1654
A10BX07
ATC
[U] liraglutide; parenteral
2.6
11.8
82
313
R60.1
ICD-10 Finland
Generalized oedema
3.8
11.8
49
131
EBA00
NOMESCO Finland
Extraction of tooth
1.2
11.7
1782
15161
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
2.5
11.7
87
346
3AC01
NOMESCO Finland
NA
2.7
11.7
81
307
SPAT1104
SPAT
Monitoring of emergency patient
1.5
11.7
414
2831
UJF92
NOMESCO Finland
Capsular endoscopy
2.2
11.6
112
505
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
3.0
11.6
67
227
J94.1
ICD-10 Finland
Fibrothorax
12.5
11.6
20
16
G72.8
ICD-10 Finland
Other specified myopathies
2.2
11.6
115
528
R03CC02
ATC
salbutamol; systemic
1.8
11.6
199
1125
2780A
ICD-9 Finland
Obesity and other hyperalimentation, Obesity
3.2
11.5
60
191
G82.5
ICD-10 Finland
Tetraplegia, unspecified
8.1
11.5
25
31
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
3.3
11.5
57
175
JDB00
NOMESCO Finland
Gastrostomy
6.5
11.5
29
45
ECB00
NOMESCO Finland
Suture of gingiva
1.8
11.5
200
1135
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
11.5
157
819
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
3.7
11.5
49
134
C02AC05
ATC
moxonidine; oral
1.6
11.5
295
1872
5192A
ICD-9 Finland
Other diseases of respiratory system, Mediastinitis
+∞
11.5
11
*
T91.3
ICD-10 Finland
Sequelae of injury of spinal cord
5.2
11.4
34
65
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.6
11.4
314
2028
FWW96
NOMESCO Finland
Other reoperation on heart or major thoracic vessels
5.4
11.4
33
61
J20.0
ICD-10 Finland
Acute bronchitis due to Mycoplasma pneumoniae
3.1
11.4
61
198
49101
ICD-8 Finland
Chronic bronchitis, Nonpurulenta (simplex)
4.0
11.4
44
110
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
4.0
11.4
44
110
X57
ICD-10 Finland
Unspecified privation
2.0
11.4
142
717
5110B
ICD-9 Finland
Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]
4.3
11.4
41
96
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
3.7
11.4
48
130
R06
ICD-10 Finland
Abnormalities of breathing
3.0
11.4
63
210
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.5
11.3
339
2232
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
2.4
11.3
93
388
R05CB02
ATC
bromhexine; systemic
2.1
11.3
128
622
SPAT1167
SPAT
Insertion of urinary catheter
1.6
11.3
261
1609
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
3.0
11.3
63
211
N05AD01
ATC
haloperidol; systemic
1.7
11.3
225
1331
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
11.3
1122
9090
ZXD10
NOMESCO Finland
Scheduled procedure
1.2
11.2
2423
21325
120
Kela drug reimbursment
Hypogammaglobulinaemia
10.5
11.2
21
20
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
4.8
11.2
36
75
RS314
NOMESCO Finland
NA
8.9
11.2
23
26
A10BH05
ATC
linagliptin; oral
1.5
11.2
342
2262
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
2.4
11.2
95
402
N05AN01
ATC
lithium; oral
2.2
11.2
112
515
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
4.5
11.2
38
84
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
2.7
11.2
74
273
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
2.3
11.2
96
412
RD160
NOMESCO Finland
NA
6.2
11.2
29
47
N04BC05
ATC
pramipexole; oral
1.5
11.1
439
3068
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.6
11.1
279
1760
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
5.4
11.1
32
59
M05BX04
ATC
denosumab; parenteral
1.6
11.1
293
1871
H05AA02
ATC
teriparatide; parenteral
4.0
11.1
43
108
M54.5
ICD-10 Finland
Low back pain
1.2
11.1
1701
14474
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
3.5
11.1
50
143
A08
ICPC
Swelling
1.6
11.1
259
1605
N05BE01
ATC
buspirone; oral
2.0
11.1
146
754
N06AX12
ATC
bupropion; oral
1.8
11.1
202
1165
SPE90
NOMESCO Finland
Other fitting and preparation of partial tooth prosthesis
1.9
11.1
148
769
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
2.8
11.1
67
237
N03AX11
ATC
topiramate; oral
2.3
11.0
95
408
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
3.4
11.0
51
149
N05AF01
ATC
flupentixol; systemic
2.3
11.0
97
422
162
Kela drug reimbursment
liraglutide
2.7
10.9
71
262
FWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of heart and major thoracic vessels
13.9
10.9
18
13
W19
ICD-10 Finland
Unspecified fall
1.4
10.9
565
4154
AP2
HP
Catheterization of the right side of the heart
4.2
10.9
40
96
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
2.9
10.9
65
228
PD5AD
NOMESCO Finland
CT of aorta
2.1
10.8
114
535
JWA00
NOMESCO Finland
Repair of wound dehiscence in gastroenterological surgery
3.3
10.8
53
162
TGW99
NOMESCO Finland
Other minor procedure in thoracic surgery
5.5
10.8
31
57
J94.9
ICD-10 Finland
Pleural condition, unspecified
3.3
10.8
52
157
N07AA02
ATC
pyridostigmine; systemic
3.8
10.8
44
116
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
2.5
10.8
86
353
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.0
10.8
126
621
GBA00
NOMESCO Finland
Tracheotomy
8.2
10.8
23
28
R01
ICPC
Pain respiratory system
2.4
10.8
86
354
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
2.1
10.7
119
574
J86.00
ICD-10 Finland
Empyema with broncho-pleural fistula
6.4
10.7
27
42
WX740
NOMESCO Finland
Nitrogen oxide therapy
6.4
10.7
27
42
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
1.8
10.7
173
959
0114
NOMESCO Finland
NA
17.8
10.7
16
9
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
2.3
10.7
95
414
J41.0
ICD-10 Finland
Simple chronic bronchitis
3.3
10.7
51
153
M81.4
ICD-10 Finland
Drug-induced osteoporosis
4.7
10.7
35
75
D07AC01
ATC
betamethasone; topical
1.2
10.6
2024
17591
ZXA00
NOMESCO Finland
Right side
1.2
10.6
1767
15157
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
4.9
10.6
33
67
C07AG02
ATC
carvedilol; oral
1.4
10.6
429
3019
WX110
NOMESCO Finland
Local anesthesy
1.2
10.6
3914
36020
J38.7
ICD-10 Finland
Other diseases of larynx
4.1
10.5
40
99
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.6
10.5
186
2959
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
2.0
10.5
126
625
R01AD08
ATC
fluticasone; nasal
1.2
10.5
1408
11807
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
10.5
152
814
SPAT1097
SPAT
Recording of ECG
1.3
10.5
928
7405
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.4
10.5
490
3538
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
1.4
10.5
494
3573
J01DA08
ATC
[U] cefaclor; oral
1.4
10.5
450
3200
P01BA02
ATC
hydroxychloroquine; oral
1.5
10.5
405
2823
RS310
NOMESCO Finland
NA
6.5
10.5
26
40
3A006
NOMESCO Finland
NA
110.1
10.4
11
*
J01MA01
ATC
ofloxacin; systemic
1.4
10.4
589
4400
R05DB20
ATC
other cough suppressants - combinations
1.5
10.4
305
2003
Z43.1
ICD-10 Finland
Attention to gastrostomy
7.7
10.3
23
30
J11.1
ICD-10 Finland
Influenza with other respiratory manifestations, virus not identified
2.2
10.3
99
449
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
1.9
10.3
156
846
D07AA02
ATC
hydrocortisone; topical
1.3
10.3
709
5459
F99
ICD-10 Finland
Mental disorder, not otherwise specified
2.4
10.3
83
343
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
1.9
10.3
138
719
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.4
10.2
444
3163
RK290
NOMESCO Finland
NA
4.6
10.2
34
74
G71.11
ICD-10 Finland
Dystrophia myotonica [Steinert]
18.8
10.2
15
8
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.1
10.2
117
571
TAB00
NOMESCO Finland
Lumbar puncture
1.7
10.2
208
1242
R10.0
ICD-10 Finland
Acute abdomen
1.8
10.2
172
968
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
2.7
10.2
66
244
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
2.6
10.2
70
268
K55.8
ICD-10 Finland
Other vascular disorders of intestine
3.4
10.2
47
138
T78.4
ICD-10 Finland
Allergy, unspecified
1.8
10.2
176
1002
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
6.6
10.2
25
38
GX1K5
NOMESCO Finland
Diffusion capacity
6.6
10.2
25
38
WW400
NOMESCO Finland
Plasmaferesis
7.4
10.1
23
31
NAG53
NOMESCO Finland
Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea
7.4
10.1
23
31
A12AA04
ATC
calcium carbonate; oral
2.1
10.1
114
553
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
4.5
10.1
34
75
XX3DW
NOMESCO Finland
Time consuming IT work
1.4
10.1
562
4185
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
1.8
10.1
179
1026
J94.2
ICD-10 Finland
Haemothorax
4.2
10.1
37
89
ZY000
NOMESCO Finland
Hospital inpatient
3.0
10.1
58
197
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
1.8
10.1
156
855
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
2.5
10.1
76
306
RS142
NOMESCO Finland
NA
7.9
10.1
22
28
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
3.3
10.0
48
145
Y0499
ICD-8 Finland
Investigation of respiratory system
2.2
10.0
96
435
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
2.7
10.0
65
241
G04BE03
ATC
sildenafil; oral
2.1
10.0
106
503
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
2.4
10.0
81
337
N18.0
ICD-10 Finland
End-stage renal disease
2.2
10.0
94
424
GEB30
NOMESCO Finland
Mediastinotomy and excision of lesion
14.6
10.0
16
11
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.8
10.0
676
8563
S10
ICPC
Boil/carbuncle
1.6
10.0
268
1724
D21
ICPC
Swallowing problem
2.2
10.0
98
449
M41.9
ICD-10 Finland
Scoliosis, unspecified
2.5
9.9
72
284
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
1.5
9.9
385
2684
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
5.5
9.9
28
51
K65.0
ICD-10 Finland
Acute peritonitis
2.3
9.9
87
378
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.5
9.9
306
2034
XCK10
NOMESCO Finland
Photography of fundus of eye
1.3
9.9
642
4902
T05
ICPC
Feeding problem of adult
3.4
9.9
46
136
C09CA01
ATC
losartan; oral
1.2
9.9
1510
12829
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
2.3
9.9
89
390
J43
ICD-10 Finland
Emphysema
6.7
9.9
24
36
J01DC02
ATC
cefuroxime; systemic
1.6
9.9
264
1698
ZXH02
NOMESCO Finland
Procedure performed inside intensive care unit
16.7
9.9
15
9
AA1
HP
Conventional CABG
1.8
9.8
165
929
RD211
NOMESCO Finland
NA
1.6
9.8
228
1414
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
2.8
9.8
62
225
21230
ICD-8 Finland
Benign neoplasm of respiratory system, Bronchus and lung
26.0
9.8
13
5
137
Kela drug reimbursment
Uraemia requiring dialysis
2.8
9.8
59
209
4610A
ICD-9 Finland
Acute sinusitis, Maxillary
2.3
9.8
86
374
N05CF02
ATC
zolpidem; oral
1.3
9.8
846
6728
R03BC01
ATC
cromoglicic acid; inhalant
2.6
9.8
70
274
51709
ICD-8 Finland
Other chronic interstitial pneumonia, Unspecified
8.7
9.8
20
23
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
9.5
9.7
19
20
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.2
9.7
91
407
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
2.2
9.7
92
416
S19
ICPC
Skin injury other
1.6
9.7
227
1409
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
2.0
9.7
113
556
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
1.6
9.7
265
1710
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
1.4
9.7
389
2730
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
1.6
9.7
223
1377
280
Kela drug reimbursment
Clopidogrel
1.9
9.7
131
687
AK3
HP
BLTX (both lung transplants)
55.0
9.6
11
*
R06.4
ICD-10 Finland
Hyperventilation
2.3
9.6
82
351
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.7
9.6
201
1212
C02EA02
ATC
NA
1.5
9.6
375
2621
R51
NOMESCO Finland
Aids services
7.8
9.6
21
27
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
2.5
9.6
72
288
X58
ICD-10 Finland
Exposure to other specified factors
1.3
9.6
657
5061
SPAT1281
SPAT
Other administrative function
1.4
9.6
432
3106
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
2.2
9.5
90
405
C08CA02
ATC
felodipine; oral
1.3
9.5
673
5203
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
1.9
9.5
138
741
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
2.7
9.5
61
224
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
3.1
9.5
50
162
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
2.0
9.5
123
632
1CX01
NOMESCO Finland
NA
8.3
9.5
20
24
N06AX05
ATC
trazodone; oral
2.0
9.5
114
568
R85
ICPC
Malignant neopl respiratory other
6.3
9.5
24
38
JDB01
NOMESCO Finland
Laparoscopic gastrostomy
9.1
9.5
19
21
T88.6
ICD-10 Finland
Anaphylactic shock due to adverse effect of correct drug or medicament properly administered
5.4
9.5
27
50
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
3.9
9.5
37
95
30310
ICD-8 Finland
Alcoholism, Habitual excessive drinking
2.7
9.5
64
242
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
3.7
9.4
39
105
A10BK03
ATC
empagliflozin; oral
1.5
9.4
347
2394
SPAT1125
SPAT
Stoma care and guidance
2.0
9.4
118
600
R03AK
ATC
Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
3.2
9.4
47
147
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
2.1
9.4
97
455
J01XB01
ATC
colistin; inhalant, parenteral
100.1
9.4
10
*
B01AC11
ATC
iloprost; inhalant, parenteral
100.1
9.4
10
*
GBC03
NOMESCO Finland
Resection of trachea
100.1
9.4
10
*
AP1
HP
Catheterization of the left side of the heart
1.9
9.4
128
669
NGQ20
NOMESCO Finland
Amputation of lower leg
2.9
9.4
55
191
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
17.5
9.4
14
8
G70.0
ICD-10 Finland
Myasthenia gravis
3.9
9.4
37
96
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.6
9.3
258
1669
DQE00
NOMESCO Finland
Implantation of prosthetic replacement for larynx
6.2
9.3
24
39
GCA05
NOMESCO Finland
Bronchoscopic laser therapy of lesion of bronchus
12.3
9.3
16
13
23130
ICD-8 Finland
Neoplasm of unspecified nature of respiratory organs, Bronchus and lung
21.7
9.3
13
6
D09AB01
ATC
zinc bandage without supplements; topical
2.0
9.3
121
624
L17
ICPC
Foot/toe symptom/complaint
1.2
9.3
1388
11758
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.0
9.3
106
521
ZX122
NOMESCO Finland
Intra-arterial
3.5
9.3
41
117
ZXA05
NOMESCO Finland
Left side
1.2
9.3
1631
14044
RS211
NOMESCO Finland
NA
4.8
9.2
29
60
FM2CE
NOMESCO Finland
NA
4.8
9.2
29
60
N18
ICPC
Paralysis/weakness
1.9
9.2
125
655
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
3.2
9.2
46
144
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
6.4
9.2
23
36
R62.0
ICD-10 Finland
Delayed milestone
5.0
9.2
28
56
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
2.2
9.2
90
411
A10BH02
ATC
vildagliptin; oral
1.8
9.2
147
817
M47.9
ICD-10 Finland
Spondylosis, unspecified
1.7
9.2
183
1087
R49.08
ICD-10 Finland
Other specified dysphonia
2.0
9.2
107
527
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
1.9
9.2
129
685
4900A
ICD-9 Finland
Bronchitis, not specified as acute or chronic[BRONCHITIS NUD]
3.2
9.2
45
139
K92.0
ICD-10 Finland
Haematemesis
1.7
9.2
172
1003
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.7
9.2
193
1166
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
2.8
9.2
58
211
J01CF05
ATC
flucloxacillin; systemic
1.7
9.1
198
1207
F10.24
ICD-10 Finland
Alcohol depence active use
2.5
9.1
70
286
ZXF00
NOMESCO Finland
Interruption caused by intraoperative deterioration of general condition
4.1
9.1
34
84
R05DA01
ATC
ethylmorphine; oral
1.4
9.1
452
3304
5119X
ICD-9 Finland
Pleurisy, Unspecified pleural effusion
3.3
9.1
43
130
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.6
9.0
225
1422
2123A
ICD-9 Finland
Benign neoplasm of respiratory and intrathoracic organs, Bronchus and lung
11.4
9.0
16
14
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
1.7
9.0
176
1038
S72.4
ICD-10 Finland
Fracture of lower end of femur
2.7
9.0
58
214
N05CD02
ATC
nitrazepam; oral
1.9
9.0
133
717
GAG30
NOMESCO Finland
Transthoracic repair of diaphragm for rupture
36.7
9.0
11
*
GBB03
NOMESCO Finland
Percutaneous tracheostomy
10.0
9.0
17
17
SPAT1299
SPAT
Other function in accordance with podiatry nomenclature
2.0
9.0
110
554
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
2.8
9.0
55
198
FNC10
NOMESCO Finland
Aorto-coronary venous bypass with single distal anastomosis
2.0
8.9
103
507
I21.40
ICD-10 Finland
Acute subendocardial infarction no detected stenosis of the coronary artery
1.6
8.9
214
1339
A02BA03
ATC
famotidine; systemic
1.5
8.9
275
1830
K05.31
ICD-10 Finland
Periodontitis pronounced
1.4
8.9
523
3932
G71.08
ICD-10 Finland
Other muscular dystrophy
7.4
8.9
20
27
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
2.0
8.9
105
522
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.6
8.9
220
1388
F2682
NOMESCO Finland
NA
6.1
8.9
23
38
13599
ICD-8 Finland
Sarcoidosis, Unspecified
3.6
8.9
38
106
GAC46
NOMESCO Finland
Partial decortication of pleura
5.7
8.9
24
42
5150X
ICD-9 Finland
Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]
5.4
8.9
25
46
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
1.6
8.8
203
1255
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
1.7
8.8
162
941
ZX100
NOMESCO Finland
Oral
2.1
8.8
100
490
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
2.8
8.8
53
189
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
2.9
8.8
52
183
RL140
NOMESCO Finland
NA
10.7
8.8
16
15
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
0.8
8.8
508
6570
81
HP
Angiography of the heart and coronary arteries
1.3
8.8
558
4250
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.5
8.8
276
1847
D07XC01
ATC
betamethasone, combinations; topical
1.3
8.7
698
5492
F20.5
ICD-10 Finland
Residual schizophrenia
3.3
8.7
41
123
N07BC02
ATC
methadone; systemic
4.5
8.7
29
64
V03AE03
ATC
lanthanum carbonate; oral
4.5
8.7
29
64
N29
ICPC
Neurological sympt/complt other
2.0
8.7
111
570
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
2.5
8.7
67
273
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
2.3
8.7
79
350
L03.3
ICD-10 Finland
Cellulitis of trunk
3.2
8.7
43
134
A01AB10
ATC
natamycin; local oral
1.7
8.7
168
990
M31.3
ICD-10 Finland
Wegener granulomatosis
4.1
8.7
32
78
XX4AW
NOMESCO Finland
NA
5.9
8.7
23
39
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.3
8.7
517
3895
C34.20
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung without histology
5.6
8.7
24
43
1440
FHL
Mediastinoscopy
7.2
8.7
20
28
H25.8
ICD-10 Finland
Other senile cataract
1.3
8.7
799
6402
V03AE02
ATC
sevelamer; oral
3.5
8.7
38
108
Z94.1
ICD-10 Finland
Heart transplant status
4.7
8.7
28
60
GAC00
NOMESCO Finland
Biopsy of pleura
3.2
8.7
44
140
30041
ICD-8 Finland
Neuroses, Depressiva
2.1
8.7
89
417
TPX15
NOMESCO Finland
Removal of vascular injection port
3.8
8.7
35
93
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
3.7
8.7
36
98
GEB10
NOMESCO Finland
Mediastinotomy
50.0
8.7
10
*
A08AA02
ATC
fenfluramine; oral (centrally acting antiobesity products)
2.6
8.7
59
224
ZXF05
NOMESCO Finland
Interruption of procedure for other patient related reason
3.2
8.6
43
135
C08CA05
ATC
nifedipine; systemic
1.4
8.6
471
3497
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
2.7
8.6
56
209
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.3
8.6
78
345
TFP20
NOMESCO Finland
Cardiodefibrillation
1.4
8.6
497
3726
J38.5
ICD-10 Finland
Laryngeal spasm
6.1
8.6
22
36
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
5.2
8.6
25
48
J85.1
ICD-10 Finland
Abscess of lung with pneumonia
5.2
8.6
25
48
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
1.7
8.6
170
1010
I20.89
ICD-10 Finland
Other angina pectoris unspecified coronary artery status
1.5
8.6
316
2184
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.5
8.5
246
1610
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.6
8.5
208
1306
R05CA10
ATC
expectorants - combinations
1.8
8.5
133
732
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.3
8.5
590
4550
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
3.4
8.5
39
115
F32.1
ICD-10 Finland
Moderate depressive episode
1.7
8.5
173
1035
WX734
NOMESCO Finland
JET-ventilation
6.9
8.5
20
29
KA1AE
NOMESCO Finland
Kidney ultrasound examination
1.8
8.5
150
861
H04.10
ICD-10 Finland
Dry eye syndrome
1.4
8.5
449
3316
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
3.1
8.5
45
148
RS224
NOMESCO Finland
NA
3.6
8.5
36
100
M79.0
ICD-10 Finland
Rheumatism, unspecified
1.8
8.5
140
785
A69
ICPC
General and Unspecified, Other reason for encounter NEC
1.7
8.5
164
969
B44.9
ICD-10 Finland
Aspergillosis, unspecified
27.5
8.5
11
*
GCA12
NOMESCO Finland
Bronchoscopic removal of foreign body
27.5
8.5
11
*
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
4.9
8.5
26
53
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
2.2
8.5
85
395
S12
ICPC
Insect bite/sting
0.7
8.4
198
2964
H3603, E103
ICD-10 Finland
NA
2.8
8.4
51
183
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
1.6
8.4
189
1165
M14.6*E11.6
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic neuropathic
4.7
8.4
27
58
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.7
8.4
285
3988
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.4
8.4
367
2626
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
2.1
8.3
89
424
J67.9
ICD-10 Finland
Hypersensitivity pneumonitis due to unspecified organic dust
6.7
8.3
20
30
J93.8
ICD-10 Finland
Other pneumothorax
3.2
8.3
41
128
7707A
ICD-9 Finland
Other respiratory conditions of foetus and newborn, Chronic respiratory disease arising in the perinatal period[DYSPLASIA BRONCHOPULMONALIS NEONATALIS]
+∞
8.3
8
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
2.7
8.3
55
208
D01AC02
ATC
miconazole; topical
1.3
8.3
495
3728
XX9TE
NOMESCO Finland
Compementary ultrasound examination
3.3
8.3
40
123
TJD10
NOMESCO Finland
Insertion of other tube into stomach or duodenum
6.2
8.3
21
34
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.3
8.3
527
4015
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
1.9
8.3
119
638
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
4.6
8.3
27
59
SPAT1310
SPAT
Counselling related to known health issue
1.2
8.2
1799
15774
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
2.2
8.2
79
362
N06AA04
ATC
clomipramine; systemic
2.1
8.2
86
408
2961C
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]
2.8
8.2
49
174
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
1.4
8.2
410
3004
J85.3
ICD-10 Finland
Abscess of mediastinum
14.5
8.2
13
9
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
1.5
8.2
263
1769
A07EC01
ATC
sulfasalazine; oral, rectal
1.4
8.2
404
2954
K43.0
ICD-10 Finland
Incisional hernia with obstruction, without gangrene
2.5
8.2
61
247
Z73.8
ICD-10 Finland
Other problems related to life-management difficulty
4.2
8.2
29
69
WZA10
NOMESCO Finland
Long statement of health and health related matters
2.3
8.2
70
304
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.2
8.1
1014
8418
L95.8
ICD-10 Finland
Other vasculitis limited to skin
4.5
8.1
27
60
RF122
NOMESCO Finland
NA
4.5
8.1
27
60
RS340
NOMESCO Finland
NA
5.1
8.1
24
47
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
2.0
8.1
101
512
46699
ICD-8 Finland
Acute bronchitis and bronchiolitis
2.4
8.1
67
286
49102
ICD-8 Finland
Chronic bronchitis, Purulenta
5.7
8.1
22
39
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.4
8.1
468
3511
-34
ICPC
Blood test
1.7
8.1
160
950
4660A
ICD-9 Finland
Acute bronchitis and bronchiolitis, Acute bronchitis
2.4
8.1
66
279
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
2.7
8.1
52
193
F32.8
ICD-10 Finland
Other depressive episodes
2.4
8.1
64
268
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
2.2
8.1
77
350
T81.9
ICD-10 Finland
Unspecified complication of procedure
2.0
8.1
92
453
1623C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,ADENOCARCINOMA]
11.7
8.1
14
12
GCA32
NOMESCO Finland
Endoscopic insertion of stent into bronch
11.7
8.1
14
12
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
1.6
8.1
222
1440
S80.1
ICD-10 Finland
Contusion of other and unspecified parts of lower leg
1.8
8.1
140
799
XG420
NOMESCO Finland
Time-volume spirometry
6.8
8.0
19
28
108
Kela drug reimbursment
Myasthenia gravis
4.0
8.0
30
75
8240/3-C34.9
ICD-O-3
Neuroendocrine tumor, NOS, of lung, NOS
22.0
8.0
11
5
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
3.6
8.0
34
95
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
2.0
8.0
92
456
JAD10
NOMESCO Finland
Repair of incisional hernia
2.6
8.0
55
211
NG4AA
NOMESCO Finland
Lower leg X-ray examination
1.8
8.0
138
789
I21.97
ICD-10 Finland
Suspected acute myocardial infarction
2.1
8.0
91
446
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
2.1
8.0
84
399
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
2.0
8.0
94
470
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
2.0
8.0
100
510
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.5
8.0
297
2058
S06
ICPC
Rash localized
1.5
8.0
284
1951
L82
ICD-10 Finland
Seborrhoeic keratosis
0.8
8.0
540
6847
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
1.8
8.0
128
712
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
2.1
8.0
89
435
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
8.0
2563
23166
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.2
7.9
2343
21035
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.2
7.9
76
345
ZXD35
NOMESCO Finland
Usual procedure
1.6
7.9
197
1245
A40.8
ICD-10 Finland
Other streptococcal sepsis
2.3
7.9
68
294
F31.8
ICD-10 Finland
Other bipolar affective disorders
2.4
7.9
65
275
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
2.7
7.9
51
189
B05DA
ATC
Isotonic solutions
2.9
7.9
44
150
F20
ICD-10 Finland
Schizophrenia
3.5
7.9
35
101
XKD06
NOMESCO Finland
Physiologic investigation of micturition
1.6
7.9
189
1185
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
3.6
7.9
34
96
EB1WA
NOMESCO Finland
NA
3.0
7.9
42
139
N30.9
ICD-10 Finland
Cystitis, unspecified
1.5
7.9
299
2080
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
2.8
7.9
47
167
D72.1
ICD-10 Finland
Eosinophilia
3.7
7.9
32
86
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.7
7.9
148
868
R03AC04
ATC
fenoterol; inhalant
3.0
7.9
43
145
7863A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Haemoptysis
3.0
7.9
43
145
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
2.1
7.9
81
382
GDB01
NOMESCO Finland
Thoracoscopic resection of bullae of lung
13.0
7.9
13
10
B96.5
ICD-10 Finland
Pseudomonas (aeruginosa) as the cause of diseases classified to other chapters
13.0
7.9
13
10
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
4.9
7.9
24
49
L16
ICPC
Ankle symptom/complaint
1.3
7.9
463
3486
ZX197
NOMESCO Finland
NA
7.7
7.9
17
22
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
2.7
7.8
51
191
M33.2
ICD-10 Finland
Polymyositis
5.1
7.8
23
45
M14.6*A52.1
ICD-10 Finland
Charcot's or tabetic arthropathy
5.1
7.8
23
45
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
3.1
7.8
40
129
4939B
ICD-9 Finland
Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]
5.4
7.8
22
41
CKC15
NOMESCO Finland
Panretinal photocoagulation
2.3
7.8
65
279
F60.8
ICD-10 Finland
Other specific personality disorders
3.8
7.8
31
82
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
2.4
7.8
62
260
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
2.4
7.8
62
260
SPAT1227
SPAT
Substance abuse rehabilitation
3.7
7.8
32
87
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
1.7
7.8
145
846
M47.82
ICD-10 Finland
Other spondylosis, cervical region
1.6
7.8
199
1270
F22.0
ICD-10 Finland
Delusional disorder
2.2
7.8
78
364
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
1.8
7.8
117
638
NAG63
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, more than 3 vertebraea
2.9
7.8
45
156
C01BD01
ATC
amiodarone; systemic
1.6
7.8
203
1300
177
Kela drug reimbursment
Insulin glargine 300 U / ml
1.9
7.8
101
525
QDA10
NOMESCO Finland
Incision of skin of lower limb
2.7
7.7
50
186
1CX08
NOMESCO Finland
NA
2.9
7.7
43
147
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.3
7.7
683
5447
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
1.4
7.7
311
2189
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
4.8
7.7
24
50
F61
ICD-10 Finland
Mixed and other personality disorders
4.0
7.7
29
73
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
2.2
7.7
70
313
SPAT1139
SPAT
Nutrition survey
1.6
7.7
185
1160
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
2.0
7.7
87
427
GBA53
NOMESCO Finland
Prosthetic repair of trachea
45.0
7.7
9
*
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
3.7
7.7
31
83
I20.01
ICD-10 Finland
Unstable angina
1.5
7.7
218
1425
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
1.8
7.7
118
648
B01AB04
ATC
dalteparin; parenteral
1.5
7.6
290
2019
J01CA08
ATC
pivmecillinam; oral
1.2
7.6
1810
15963
M01AH02
ATC
rofecoxib; oral
1.3
7.6
789
6415
H03AA01
ATC
levothyroxine sodium; systemic
1.2
7.6
1179
10008
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
3.2
7.6
37
115
I25.5
ICD-10 Finland
Ischaemic cardiomyopathy
1.7
7.6
140
816
ZX121
NOMESCO Finland
Central venous catheter
3.9
7.6
29
74
C61
ICD-10 Finland
Malignant neoplasm of prostate
0.8
7.6
546
6874
E000002
ATC
NA
1.3
7.6
531
4098
4940A
ICD-9 Finland
Bronchiectasis[BRONCHIECTASIAE]
4.7
7.6
24
51
J14
ICD-10 Finland
Pneumonia due to Haemophilus influenzae
18.3
7.6
11
6
H26.02
ICD-10 Finland
Presenil cataract
1.8
7.6
125
704
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
1.7
7.6
150
892
0110A
ICD-9 Finland
Pulmonary tuberculosis, Tuberculosis of lung, infiltrative[TUBERCULOSIS PULMONUM INFILTRATIVA, BAKTER.VARMA]
8.0
7.6
16
20
G71.9
ICD-10 Finland
Primary disorder of muscle, unspecified
6.7
7.6
18
27
188
Kela drug reimbursment
Psychosis requiring demanding treatment
2.6
7.6
50
190
OAA67
SPAT
NA
0.5
7.6
75
1371
NXL00
NOMESCO Finland
Biopsy of muscle
4.2
7.6
27
65
WX720
NOMESCO Finland
Own respiration
1.6
7.6
188
1189
L04AA13
ATC
leflunomide; oral
1.8
7.6
115
630
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
3.4
7.6
34
100
A02BX02
ATC
sucralfate; oral
1.5
7.5
273
1885
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
2.6
7.5
53
208
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
4.0
7.5
28
70
N06AG02
ATC
moclobemide; oral
1.5
7.5
221
1459
I83.2
ICD-10 Finland
Varicose veins of lower extremities with both ulcer and inflammation
2.7
7.5
49
184
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
8.8
7.5
15
17
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
2.8
7.5
45
161
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.4
7.5
290
2028
L73.2
ICD-10 Finland
Hidradenitis suppurativa
3.0
7.5
40
133
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
3.7
7.5
31
85
Z57.2
ICD-10 Finland
Occupational exposure to dust
3.8
7.5
30
80
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.5
7.5
211
1376
UJC02
NOMESCO Finland
Rigid oesophagoscopy
2.6
7.5
52
201
-56
ICPC
Dressing/pressure/compress/tamponade
1.9
7.5
103
547
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.3
7.5
525
4059
N91.1
ICD-10 Finland
Secondary amenorrhoea
3.2
7.5
37
117
J01CF02
ATC
cloxacillin; systemic
1.7
7.5
149
889
SPD01
NOMESCO Finland
Mucosa-supported complete denture
2.6
7.5
52
202
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
1.5
7.5
250
1698
L76
ICPC
Fracture: other
1.7
7.5
154
927
I74.3
ICD-10 Finland
Embolism and thrombosis of arteries of lower extremities
2.1
7.4
80
384
F05.9
ICD-10 Finland
Delirium, unspecified
1.7
7.4
142
839
ZXD40
NOMESCO Finland
Procedure on patient requiring isolation
4.0
7.4
28
71
383
Kela drug reimbursment
Selexipag
80.1
7.4
8
*
B01AC27
ATC
selexipag; oral
80.1
7.4
8
*
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.4
7.4
301
2124
XJC10
NOMESCO Finland
Oesophageal pH monitoring
3.0
7.4
39
129
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
7.4
2380
21481
G71.00
ICD-10 Finland
Muscular dystrophy benign [Becker]
13.3
7.4
12
9
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.3
7.4
624
4948
ZXE90
NOMESCO Finland
More than 22 hours
2.2
7.3
67
300
Z49.0
ICD-10 Finland
Preparatory care for dialysis
2.3
7.3
64
280
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
1.7
7.3
155
943
ZYC01
NOMESCO Finland
Remote contact by phone
1.5
7.3
203
1321
Z72.1
ICD-10 Finland
Alcohol use
2.3
7.3
64
281
R1260
NOMESCO Finland
Evaluation of communicative skills
1.8
7.3
111
608
I44.0
ICD-10 Finland
Atrioventricular block, first degree
1.9
7.3
105
564
T78.0
ICD-10 Finland
Anaphylactic shock due to adverse food reaction
8.3
7.3
15
18
GAC47
NOMESCO Finland
Endoscopic partial decortication of pleura
8.3
7.3
15
18
A10AB06
ATC
insulin glulisine; parenteral
2.3
7.3
62
270
A220_
NOMESCO Finland
NA
+∞
7.3
7
*
Q31.1
ICD-10 Finland
Congenital subglottic stenosis
+∞
7.3
7
*
A10BG02
ATC
rosiglitazone; oral
1.9
7.3
97
509
B80
ICPC
Iron deficiency anaemia
1.9
7.3
101
538
5823
FHL
Lung avobiopsy and wedge resection
6.8
7.3
17
25
R09.3
ICD-10 Finland
Abnormal sputum
2.4
7.3
58
244
P16
ICPC
Acute alcohol abuse
2.3
7.3
66
294
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.5
7.2
243
1652
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
1.6
7.2
177
1119
RS110
NOMESCO Finland
NA
4.5
7.2
24
54
G41.9
ICD-10 Finland
Status epilepticus, unspecified
2.7
7.2
45
166
K20
ICD-10 Finland
Oesophagitis
2.0
7.2
92
474
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.3
7.2
609
4826
R41.0
ICD-10 Finland
Disorientation, unspecified
1.5
7.2
214
1415
602
Kela drug reimbursment
Children's severe malnutrition
5.4
7.2
20
37
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
1.8
7.2
110
605
J01CA02
ATC
pivampicillin; oral
1.7
7.2
136
802
A15.1
ICD-10 Finland
Tuberculosis of lung, confirmed by culture only
4.6
7.2
23
50
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.4
7.2
323
2327
XG413
NOMESCO Finland
Spirometry with oscillometry
7.3
7.2
16
22
J21.9
ICD-10 Finland
Acute bronchiolitis, unspecified
3.2
7.2
35
110
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
2.6
7.2
47
178
J11.0
ICD-10 Finland
Influenza with pneumonia, virus not identified
3.4
7.2
32
94
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.2
7.2
877
7265
I12.0
ICD-10 Finland
Hypertensive renal disease with renal failure
2.2
7.1
69
319
D50.8
ICD-10 Finland
Other iron deficiency anaemias
2.1
7.1
78
378
G04CA02
ATC
tamsulosin; oral
1.2
7.1
1971
17579
K78
ICPC
Atrial fibrillation/flutter
1.3
7.1
558
4377
S42.2
ICD-10 Finland
Fracture of upper end of humerus
1.5
7.1
240
1630
I21.90
ICD-10 Finland
Myocardial infarction (acute) UNS no detected stenosis of the coronary artery
1.6
7.1
158
974
B05XA03
ATC
sodium chloride; parenteral
20.0
7.1
10
5
SPAT1279
SPAT
Preparation of immediate hospitalisation
2.0
7.1
83
415
S01BC05
ATC
ketorolac; ophthalmic
1.4
7.1
300
2135
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
1.9
7.1
100
537
Z50.4
ICD-10 Finland
Psychotherapy, not elsewhere classified
6.5
7.1
17
26
L01BB01
ATC
NA
5.0
7.1
21
42
K85
ICD-10 Finland
Acute pancreatitis
1.8
7.1
111
616
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
2.0
7.1
87
445
NA1CM
NOMESCO Finland
Cervical spine extensive MRI examination with 3 Tesla magnet
5.6
7.0
19
34
2AX04
NOMESCO Finland
NA
8.8
7.0
14
16
A10BK01
ATC
dapagliflozin; oral
1.5
7.0
206
1361
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
1.6
7.0
170
1073
K56.7
ICD-10 Finland
Ileus, unspecified
1.8
7.0
109
605
T89
ICPC
Diabetes insulin dependent
1.6
7.0
165
1034
NFJ62
NOMESCO Finland
Internal fixation of fracture of other parts of femur with plate
2.5
7.0
51
206
D07AB08
ATC
desonide; topical
1.3
7.0
558
4392
RK210
NOMESCO Finland
NA
4.7
7.0
22
47
S51.9
ICD-10 Finland
Open wound of forearm, part unspecified
2.6
7.0
47
182
R79
ICPC
Chronic bronchitis
4.9
6.9
21
43
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
1.9
6.9
102
553
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.1
6.9
2409
21843
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
3.9
6.9
26
66
NG1DA
NOMESCO Finland
X-ray of knees
1.9
6.9
94
496
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
2.0
6.9
77
378
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
4.4
6.9
23
52
F54
ICD-10 Finland
Psychological and behavioural factors associated with disorders or diseases classified elsewhere
4.4
6.9
23
52
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.2
6.9
878
7303
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
0.4
6.9
31
729
A06AH03
ATC
naloxegol; oral
2.2
6.9
64
289
30300
ICD-8 Finland
Alcoholism, Episodic excessive drinking
2.0
6.9
79
392
K22.4
ICD-10 Finland
Dyskinesia of oesophagus
2.8
6.9
42
153
I80.9
ICD-10 Finland
Phlebitis and thrombophlebitis of unspecified site
2.1
6.9
76
369
ZYY98
NOMESCO Finland
Missed treatment contact, no notification given by patient
5.8
6.9
18
31
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
1.7
6.9
137
821
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
2.0
6.9
81
407
SPAT1298
SPAT
Other function in accordance with nutritional therapy nomenclature
2.5
6.9
50
202
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
1.9
6.9
92
486
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
2.1
6.9
72
346
U05
ICPC
Urination problems other
1.4
6.8
271
1907
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
6.8
113
640
WX213
NOMESCO Finland
Lower leg blockade
2.4
6.8
52
214
N05AB01
ATC
dixyrazine; systemic
2.1
6.8
74
360
S09
ICPC
Infected finger/toe
1.7
6.8
141
852
M86.8
ICD-10 Finland
Other osteomyelitis
4.8
6.8
21
44
51101
ICD-8 Finland
Pleurisy, Adhaesiones pleurae
4.8
6.8
21
44
N05AL01
ATC
sulpiride; systemic
2.0
6.8
85
437
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
2.6
6.8
45
172
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
6.7
6.8
16
24
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
6.7
6.8
16
24
29580
ICD-8 Finland
Schizophrenia, Other
3.3
6.8
31
93
P28
ICPC
Limited function/disability (P)
2.7
6.8
44
165
H05BX01
ATC
cinacalcet; oral
2.8
6.8
41
149
FB1BC
NOMESCO Finland
Extensive angiography of arteria pulmonalis
9.3
6.8
13
14
Z31.5
ICD-10 Finland
Genetic counselling
1.6
6.8
149
916
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
2.1
6.8
73
353
K42.0
ICD-10 Finland
Umbilical hernia with obstruction, without gangrene
2.1
6.8
68
319
G71.03
ICD-10 Finland
Muscular dystrophy autosomal recessive, childhood type, resembling Duchenne or Becker
40.0
6.8
8
*
F20.8
ICD-10 Finland
Other schizophrenia
4.0
6.7
25
63
M35.8
ICD-10 Finland
Other specified systemic involvement of connective tissue
5.3
6.7
19
36
B37.7
ICD-10 Finland
Candidal sepsis
5.3
6.7
19
36
A10BX04
ATC
[U] exenatide; parenteral
2.3
6.7
57
246
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
2.0
6.7
82
417
196
Kela drug reimbursment
Paricalcitol and cinacalcet
3.1
6.7
34
110
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
3.1
6.7
34
110
R03
ICPC
Wheezing
2.2
6.7
61
275
Y94.0
ICD-10 Finland
Accident at home
1.8
6.7
110
620
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
2.7
6.7
41
150
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
1.4
6.7
358
2654
A49.0
ICD-10 Finland
Staphylococcal infection, unspecified site
3.1
6.7
33
105
Y96.9
ICD-10 Finland
Unspecified type of accident
1.9
6.7
84
434
1623E
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA ALIA DEF/NUD]
22.5
6.7
9
*
A222_
NOMESCO Finland
NA
22.5
6.7
9
*
WX402
NOMESCO Finland
General anaesthesia
1.2
6.7
747
6127
SPAT1094
SPAT
Continuous Positive Airway Pressure
2.2
6.7
60
269
RS313
NOMESCO Finland
NA
3.5
6.7
29
84
S20
ICPC
Corn/callosity
1.7
6.7
117
676
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
2.6
6.6
45
175
SPAT1151
SPAT
Treatment of major wounds
2.0
6.6
79
398
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
1.5
6.6
213
1435
R84
ICPC
Malignant neoplasm bronchus/lung
3.1
6.6
33
106
C08CA13
ATC
lercanidipine; oral
1.2
6.6
791
6539
DQB30
NOMESCO Finland
Laryngectomy
5.1
6.6
19
37
F13.24
ICD-10 Finland
Addiction relationship caused by sedative and hypnotic active addiction
5.1
6.6
19
37
GWE00
NOMESCO Finland
Reoperation for deep haemorrhage in thoracic surgery
5.9
6.6
17
29
K22.3
ICD-10 Finland
Perforation of oesophagus
5.5
6.6
18
33
F25.2
ICD-10 Finland
Schizoaffective disorder, mixed type
5.5
6.6
18
33
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
5.5
6.6
18
33
5822
FHL
Exploratory thoracotomy and small procedure (eg lung suture)
5.5
6.6
18
33
K99
ICPC
Cardiovascular disease other
1.6
6.6
173
1115
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
1.5
6.6
184
1205
F83
ICD-10 Finland
Mixed specific developmental disorders
4.6
6.6
21
46
R4120
NOMESCO Finland
Occupational therapy
1.4
6.6
306
2219
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.3
6.5
562
4468
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
1.5
6.5
191
1262
J01CE02
ATC
phenoxymethylpenicillin; oral
1.1
6.5
3980
37392
SPAT1307
SPAT
Psychosocial counselling and guidance
1.5
6.5
180
1174
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
6.8
6.5
15
22
NF1AA
NOMESCO Finland
Hip X-ray examination
1.3
6.5
514
4044
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
1.7
6.5
136
824
TAC99
NOMESCO Finland
Other blockade for chronic pain
2.7
6.5
42
157
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
4.1
6.5
23
56
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
2.2
6.5
61
279
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
2.7
6.5
42
158
XX2VW
NOMESCO Finland
Radiologic consultation
3.6
6.4
27
76
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.3
6.4
488
3817
ZXE70
NOMESCO Finland
Moren than 15 and less than 18 hours
3.7
6.4
26
71
F45.0
ICD-10 Finland
Somatization disorder
3.8
6.4
25
66
FCA60
NOMESCO Finland
Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis
3.8
6.4
25
66
RS140
NOMESCO Finland
NA
5.3
6.4
18
34
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
5.3
6.4
18
34
J01DC04
ATC
cefaclor; oral
2.2
6.4
59
268
R21
NOMESCO Finland
Counselling and guidance in rehabilitation
2.3
6.4
55
239
G12.9
ICD-10 Finland
Spinal muscular atrophy, unspecified
5.7
6.4
17
30
B37.0
ICD-10 Finland
Candidal stomatitis
2.4
6.4
52
220
FKE05
NOMESCO Finland
Mitral valvuloplasty
69.9
6.4
7
*
A221_
NOMESCO Finland
NA
69.9
6.4
7
*
GBA60
NOMESCO Finland
Management of tracheostomy
69.9
6.4
7
*
334
Kela drug reimbursment
Treprostinil
69.9
6.4
7
*
A29
ICPC
General symptom/complaint other
1.3
6.4
623
5027
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
2.1
6.4
68
327
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
1.6
6.4
139
854
SPD00
NOMESCO Finland
Fitting and preparation of total teeth prosthesis
2.0
6.4
75
376
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
1.7
6.4
130
782
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.3
6.4
369
2772
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
2.0
6.4
75
377
FXF00
NOMESCO Finland
Decannulation after ECHLA or ECLA
14.3
6.4
10
7
J39.9
ICD-10 Finland
Disease of upper respiratory tract, unspecified
3.2
6.4
31
98
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.3
6.4
445
3442
7860A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Dyspnoea and respiratory abnormalities[DYSPNOEA]
2.2
6.4
58
262
78020
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Convulsions
2.4
6.4
50
211
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
2.4
6.4
50
211
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
4.0
6.4
23
57
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
1.6
6.4
153
965
1623A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA EPIDERMOIDES]
3.7
6.3
25
67
QBB99
NOMESCO Finland
Other procedure for wound of skin of trunk
3.7
6.3
25
67
T14.5
ICD-10 Finland
Injury of blood vessel(s) of unspecified body region
2.7
6.3
39
144
R49.8
ICD-10 Finland
Other and unspecified voice disturbances
2.2
6.3
61
284
GAE10
NOMESCO Finland
Closure of previous incision of chest wall
6.5
6.3
15
23
RK112
NOMESCO Finland
NA
6.5
6.3
15
23
GWW96
NOMESCO Finland
Other reoperation in thoracic surgery
8.1
6.3
13
16
JDA32
NOMESCO Finland
Endoscopic injection in stomach or pylorus
3.0
6.3
33
110
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.4
6.3
234
1628
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
1.6
6.3
146
913
Y77
ICPC
Malignant neoplasm prostate
0.6
6.3
91
1507
PBU84
NOMESCO Finland
Plastic repair of arteriovenous fistula from artery of upper extremity
5.9
6.3
16
27
F1246
NOMESCO Finland
NA
4.2
6.3
22
53
F60.0
ICD-10 Finland
Paranoid personality disorder
4.2
6.3
22
53
R03CC03
ATC
terbutaline; systemic
2.0
6.3
72
359
F60.2
ICD-10 Finland
Dissocial personality disorder
5.5
6.3
17
31
B90.2
ICD-10 Finland
Sequelae of tuberculosis of bones and joints
9.2
6.3
12
13
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
3.5
6.3
27
78
M10.2
ICD-10 Finland
Drug-induced gout
3.5
6.3
27
78
K86.08
ICD-10 Finland
Alcohol-induced chronic pancreatitis
3.1
6.3
32
105
G71.0
ICD-10 Finland
Muscular dystrophy
18.0
6.3
9
5
E9509
ICD-8 Finland
Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances
2.6
6.3
42
163
WX780
NOMESCO Finland
Remote monitoring CPAP
1.6
6.3
152
962
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
1.9
6.3
85
453
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
1.6
6.2
144
900
JCE33
NOMESCO Finland
Closure of acquired tracheo-oesophageal or broncho-oesophageal fistula
+∞
6.2
6
*
51901
ICD-8 Finland
Other diseases of respiratory system, Collapsus pulmonis NUD
+∞
6.2
6
*
R63.4
ICD-10 Finland
Abnormal weight loss
1.5
6.2
183
1209
XX1VW
NOMESCO Finland
Written report from radiologist
2.6
6.2
41
156
I24.9
ICD-10 Finland
Acute ischaemic heart disease, unspecified
2.6
6.2
41
156
H3601, E113
ICD-10 Finland
NA
1.8
6.2
100
562
WX732
NOMESCO Finland
High frequency respirator
26.7
6.2
8
*
RK230
NOMESCO Finland
NA
26.7
6.2
8
*
E83.51
ICD-10 Finland
Hypocalcemia
2.9
6.2
34
117
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
2.7
6.2
38
140
Z28
ICPC
Limited function/disability (Z)
2.6
6.2
42
164
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
2.8
6.2
36
127
TK820
NOMESCO Finland
Peritoneal dialysis
3.2
6.2
30
95
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.3
6.2
411
3154
G47.2
ICD-10 Finland
Disorders of the sleep-wake schedule
4.1
6.2
22
54
XW000
NOMESCO Finland
Bone marrow biopsy
1.4
6.2
231
1612
I78.8
ICD-10 Finland
Other diseases of capillaries
3.5
6.2
26
74
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
2.5
6.2
44
175
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
5.0
6.2
18
36
F2680
NOMESCO Finland
NA
3.9
6.2
23
59
M01AB51
ATC
indometacin, combinations; oral, rectal
1.6
6.2
146
918
N03AB02
ATC
phenytoin; systemic
1.9
6.1
80
420
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
6.3
6.1
15
24
J01MA11
ATC
grepafloxacin; oral
6.3
6.1
15
24
F41.01
ICD-10 Finland
Severe panic disorder
4.5
6.1
20
45
WW200
SPAT
NA
0.7
6.1
246
3350
L95
ICPC
Osteoporosis
1.6
6.1
146
920
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
1.5
6.1
168
1094
B35.3
ICD-10 Finland
Tinea pedis
1.5
6.1
179
1185
Z50.0
ICD-10 Finland
Cardiac rehabilitation
1.9
6.1
82
435
N06AB05
ATC
paroxetine; oral
1.4
6.1
236
1653
N05BB01
ATC
hydroxyzine; systemic
1.4
6.1
324
2403
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
1.4
6.1
282
2042
N06DA03
ATC
rivastigmine; oral, transdermal
0.7
6.1
136
2050
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
2.1
6.1
66
321
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
2.1
6.1
66
321
B44.0
ICD-10 Finland
Invasive pulmonary aspergillosis
7.7
6.1
13
17
Z22.3
ICD-10 Finland
Carrier of other specified bacterial diseases
3.4
6.1
27
80
L99
ICPC
Musculoskeletal disease other
1.8
6.1
95
529
Y89.9
ICD-10 Finland
Sequelae of unspecified external cause
2.3
6.1
53
234
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.2
6.1
1293
11282
SPAT1081
SPAT
Cardiorespiratory global assessment
1.4
6.1
334
2492
L29
ICPC
Musculoskeletal sympt/complt other
1.3
6.1
359
2711
13597
ICD-8 Finland
Sarcoidosis, Suspecta
2.7
6.1
37
136
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
4.6
6.1
19
41
M46.4
ICD-10 Finland
Discitis, unspecified
2.9
6.1
35
122
B44.8
ICD-10 Finland
Other forms of aspergillosis
12.5
6.1
10
8
XG480
NOMESCO Finland
Histamine provocation of respiratroy tract
2.1
6.1
59
276
M01AG02
ATC
tolfenamic acid; oral, rectal
1.3
6.1
588
4749
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.7
6.1
213
2958
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
2.0
6.0
68
337
J43.0
ICD-10 Finland
MacLeod syndrome
8.6
6.0
12
14
FXA10
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia at concurrent surgical procedure
8.6
6.0
12
14
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
1.6
6.0
137
854
R49.01
ICD-10 Finland
Functional dysphonia
1.6
6.0
135
837
A96
ICPC
Death
2.6
6.0
40
154
R25.2
ICD-10 Finland
Cramp and spasm
1.7
6.0
109
636
J01XE01
ATC
nitrofurantoin; oral
1.8
6.0
96
537
Z29
ICPC
Social problem NOS
1.8
6.0
98
554

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(1616796) Gas panel - Central venous blood
753
1679
4.81
314.58
8.1
3.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
2336
7875
3.67
307.65
11.7
6.8
%
92.3
95.6
70.97
2246
7556
(3009343) pH of Capillary blood
1721
4975
4.06
307.65
8.7
3.8
ph
7.4
7.4
0.88
269
582
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
1725
5042
4.01
307.65
8.8
3.8
kpa
5.8
5.1
94.96
1673
4586
(3023419) Bacteria identified in Sputum by Culture
672
836
8.62
307.65
3.2
2.4
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
2729
8771
4.06
307.65
11.3
6.5
kpa
5.7
5.0
103.96
2605
8295
(3022313) Gas panel - Capillary blood
1243
3626
3.83
307.65
9.2
4.0
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
1431
3934
4.15
307.65
11.2
8.4
mmol/l
25.9
24.1
55.55
1328
3603
(3003396) Base excess in Arterial blood by calculation
2698
8751
4.00
307.65
11.4
6.5
mmol/l
3.0
0.9
97.47
2331
6656
(3019060) Gas panel - Arterial blood
2321
5027
5.91
307.65
6.9
4.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
2772
12724
2.72
307.65
2.8
1.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
1697
4805
4.13
307.65
8.5
3.8
mmol/l
3.6
1.6
71.02
1494
3438
(3027801) Oxygen [Partial pressure] in Arterial blood
2727
8769
4.05
307.65
11.3
6.4
kpa
9.4
12.1
211.61
2596
8278
(3023368) Bacteria identified in Blood by Culture
4002
21679
2.55
307.65
6.8
4.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
1009
2690
4.11
307.65
3.4
2.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
820
2016
4.38
302.73
6.5
3.1
mmol/l
27.2
24.4
38.44
769
1745
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1765
7180
2.82
294.44
13.9
7.2
g/l
125.6
120.1
19.22
1713
6916
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
731
1678
4.66
294.26
2.4
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
705
1614
4.66
284.53
2.4
1.6
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
774
1939
4.28
278.19
7.0
3.9
kpa
7.6
8.1
12.62
747
1787
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1965
8789
2.59
269.20
2.7
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1965
8810
2.58
267.71
2.6
1.7
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
1241
4444
3.09
258.71
13.8
7.1
mmol/l
27.2
24.6
57.51
1225
4401
(3027315) Oxygen [Partial pressure] in Blood
696
1699
4.36
258.37
11.3
3.5
kpa
8.0
8.5
9.51
681
1654
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
577
1211
5.03
258.15
2.1
1.4
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
691
1693
4.34
255.22
11.4
3.5
kpa
5.6
4.9
49.13
676
1649
(3008152) Bicarbonate [Moles/volume] in Arterial blood
1319
4926
2.97
255.06
13.9
6.3
mmol/l
26.8
24.4
62.21
1260
4599
(3012501) Base excess in Blood by calculation
690
1693
4.34
254.35
11.4
3.5
mmol/l
4.2
2.4
28.51
599
1115
(3010421) pH of Blood
744
1952
4.07
250.62
11.1
3.5
ph
7.4
7.4
2.28
675
1652
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
987
3147
3.41
249.17
10.4
4.2
mmol/l
26.4
24.6
47.20
955
2830
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
3870
23785
2.12
245.67
4.9
3.2
ng/l
2281.9
1869.4
3.91
3492
20524
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
677
1683
4.27
245.11
1.9
1.5
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
1652
7097
2.63
243.52
11.1
6.7
mmol/l
11.3
11.0
0.61
1572
6676
(3021901) Oxygen saturation in Capillary blood
625
1481
4.47
240.75
5.4
2.7
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
2306
11665
2.32
237.10
5.9
3.2
mmol/l
0.8
0.8
0.13
2133
10766
(3003458) Phosphate [Moles/volume] in Serum or Plasma
2050
9880
2.40
235.39
8.8
5.7
mmol/l
1.1
1.0
5.26
1895
9072
(3042631) Mycobacterium sp identified in Specimen
517
1068
5.08
235.31
3.1
2.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
338
503
6.95
216.34
2.6
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
3702
23195
2.03
214.84
8.4
5.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
536
1241
4.53
212.20
2.5
1.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
964
3331
3.13
211.75
2.8
1.9
ug/l
2.1
2.5
0.36
833
2885
(3022096) Basophils/100 leukocytes in Blood
4487
30239
1.98
209.82
8.9
5.9
%
0.6
0.6
26.09
4269
27850
(3017569) Oxygen content in Arterial blood
283
360
8.09
208.05
2.8
1.9
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
456
951
5.00
204.92
1.2
1.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
4556
31091
1.96
202.94
9.0
5.8
%
2.5
2.9
28.97
4332
28599
(3019069) Monocytes/100 leukocytes in Blood
4570
31251
1.96
201.97
9.4
6.1
%
8.7
8.9
4.30
4351
28846
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
452
951
4.96
200.98
1.8
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
482
1080
4.66
198.61
1.8
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
4731
32915
1.94
196.64
8.4
5.5
e9/l
0.7
0.6
28.98
4255
27892
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
2517
14054
2.11
196.60
2.5
1.7
mg/l
1.5
1.5
0.11
2062
10851
(3006315) Basophils [#/volume] in Blood
4745
33130
1.94
194.19
8.4
5.6
e9/l
0.0
0.0
0.01
4269
28114
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
453
986
4.79
193.34
2.3
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
4854
34184
1.93
193.15
9.1
5.7
e9/l
0.2
0.2
1.44
4398
29405
(3002030) Lymphocytes/100 leukocytes in Blood
4601
31906
1.92
191.03
9.2
6.0
%
22.3
26.5
119.07
4366
29280
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
450
990
4.74
189.54
2.1
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
399
799
5.18
187.78
2.6
1.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
4780
33783
1.91
184.94
8.6
5.7
e9/l
1.7
1.9
5.01
4331
29188
(3018010) Neutrophils/100 leukocytes in Blood
4508
31394
1.89
181.16
8.9
5.8
%
62.7
58.2
108.38
4287
28960
(40767503) Oxygen content in Capillary blood by calculation
576
1630
3.71
172.87
4.7
2.4
%
16.2
15.9
1.07
350
855
(3042936) Bacteria identified in Isolate by Culture
1921
10142
2.14
170.34
2.9
2.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
1017
4079
2.69
168.06
17.9
9.0
—
—
—
0
0
(3020891) Body temperature
822
3034
2.88
158.89
8.8
4.5
—
—
—
0
0
(3019977) pH of Arterial blood
267
434
6.31
156.75
3.1
2.1
ph
7.4
7.4
0.58
177
136
(44806118)
353
747
4.88
155.54
2.5
1.4
—
—
—
0
0
(44790048)
353
747
4.88
155.54
2.5
1.4
—
—
—
0
0
(44790047)
353
747
4.88
155.54
2.5
1.4
—
—
—
0
0
(44790049)
353
747
4.88
155.54
2.5
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
355
758
4.84
154.75
4.0
3.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
1498
7447
2.22
153.01
5.8
4.0
mmol/l
3.7
1.7
45.34
1270
5968
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1501
7468
2.22
153.01
5.8
4.0
kpa
6.5
5.8
61.66
1429
7229
(3005322) IgE [Units/volume] in Serum or Plasma
838
3202
2.79
151.55
1.5
1.3
u/ml
176.9
239.9
2.12
779
2937
(3012544) pH of Venous blood
1535
7739
2.19
151.24
5.7
4.0
ph
7.4
7.4
0.08
14
39
(3014111) Lactate [Moles/volume] in Serum or Plasma
1387
6787
2.24
146.79
12.4
6.3
mmol/l
1.4
1.4
0.05
1306
6470
(3006184) Hemoglobin [Mass/volume] in Capillary blood
566
1763
3.36
146.16
3.5
2.1
g/l
132.1
126.5
4.11
410
1285
(3032080) INR in Blood by Coagulation assay
4316
31032
1.76
143.45
15.5
10.7
inr
1.3
1.3
0.04
1332
8459
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
1186
5484
2.34
143.35
2.0
1.6
—
—
—
0
0
(4010399)
1055
4632
2.45
143.27
1.8
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
1321
6473
2.22
138.74
13.8
7.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
763
2909
2.78
138.14
5.4
3.0
u/ml
0.3
0.3
2.64
502
1640
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
4498
32968
1.74
137.54
12.9
6.0
mmol/l
1.2
1.2
23.16
4132
29540
(3005719) IgG [Mass/volume] in Serum or Plasma
1044
4692
2.39
134.15
3.6
2.7
g/l
9.8
10.6
6.81
965
4258
(3028271) Lactate [Moles/volume] in Capillary blood
430
1196
3.73
131.87
3.3
1.8
mmol/l
1.6
1.7
1.19
423
1171
(3013650) Neutrophils [#/volume] in Blood by Automated count
5010
38339
1.71
126.53
12.0
8.6
e9/l
5.0
4.3
70.80
4529
33037
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
4806
36385
1.70
126.16
8.5
6.0
umol/l
11.5
12.4
5.61
4600
34381
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
1384
7164
2.11
125.40
4.8
3.1
ng/l
283.8
255.3
1.21
1293
6553
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
1002
4620
2.32
120.76
1.8
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
1527
8302
2.01
120.61
2.4
1.8
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
865
3761
2.44
119.00
5.7
4.3
mmol/l
25.6
24.0
24.81
781
3377
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1277
6626
2.08
114.15
2.8
2.2
g/l
0.2
0.2
2.24
1185
6086
(3014007) Fractional oxyhemoglobin in Arterial blood
1007
4763
2.26
113.90
16.8
8.2
%
91.1
93.9
24.42
998
4742
(3018851) Theophylline [Moles/volume] in Serum or Plasma
96
60
16.16
113.00
2.2
1.5
umol/l
44.8
42.6
0.20
96
60
(3037692) Legionella sp identified in Specimen by Organism specific culture
162
220
7.48
112.42
2.1
1.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
4740
36432
1.65
111.49
13.3
6.7
mmol/l
1.2
1.2
28.72
3945
30468
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
266
588
4.63
110.99
2.2
1.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
210
388
5.52
107.84
4.2
3.7
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
831
3704
2.37
107.73
2.1
1.8
g/l
1.2
1.3
0.43
746
3324
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
507
1768
2.98
107.64
1.8
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
507
1768
2.98
107.64
1.8
1.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
610
2349
2.72
107.62
13.1
5.6
mmol/l
1.3
1.3
0.21
541
2082
(3014576) Chloride [Moles/volume] in Serum or Plasma
1662
9640
1.89
107.20
13.4
6.5
mmol/l
103.1
104.5
21.25
1605
9419
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
3880
28593
1.64
105.99
6.6
4.1
ng/l
74.0
82.4
0.13
3220
21613
(3009445) Proteinase 3 Ab [Units/volume] in Serum
712
2984
2.51
105.63
1.8
1.5
u/ml
13.9
18.2
0.36
25
78
(3023183) Ammonium ion [Moles/volume] in Plasma
456
1516
3.12
105.20
2.6
2.6
umol/l
33.9
34.3
0.10
397
1260
(3022948) Iron [Moles/volume] in Serum or Plasma
1964
12092
1.80
104.18
3.5
2.5
umol/l
10.7
12.4
20.77
1808
11059
(3024561) Albumin [Mass/volume] in Serum or Plasma
4179
31516
1.62
102.86
7.2
4.8
g/l
32.5
34.7
93.68
3883
28964
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1763
10570
1.83
101.79
3.6
2.6
%
19.1
22.0
14.83
1460
8869
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
978
4782
2.18
101.31
17.1
8.1
%
0.6
0.7
4.03
970
4737
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
396
1247
3.28
99.97
13.3
5.0
iu/ml
704.4
2578.7
0.68
93
180
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
975
4789
2.16
99.76
17.0
8.0
%
1.6
1.3
9.04
967
4748
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
226
478
4.83
99.47
1.3
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
189
343
5.61
98.94
1.5
1.3
u/ml
1.1
1.5
0.24
113
166
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
343
1001
3.52
97.64
8.7
6.5
mg/l
11.6
12.1
1.06
316
909
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1830
11244
1.79
96.81
3.5
2.5
g/l
2.3
2.3
1.08
1682
10285
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
501
1849
2.81
95.69
4.7
2.7
g/l
3.7
3.6
1.12
476
1751
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
553
2161
2.66
94.52
1.9
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
959
4797
2.12
93.31
2.2
1.7
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
222
488
4.64
93.24
2.0
1.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
1151
6182
1.99
92.14
5.3
3.5
kpa
4.7
4.5
3.09
1091
5955
(3000494) Fungus identified in Specimen by Culture
1330
7505
1.91
92.02
2.4
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
5174
41698
1.58
91.62
11.1
4.8
mmol/l
7.1
6.9
12.77
4970
39162
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
202
419
4.91
90.98
2.1
1.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1068
5614
2.03
90.76
2.2
2.2
nmol/l
345.6
375.9
4.10
982
5099
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
202
420
4.90
90.73
2.1
1.4
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
629
2674
2.46
90.11
3.4
2.2
ug/l
667.3
635.8
0.04
594
2535
(3000492) Spirometry study
1025
5323
2.05
90.04
2.0
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2881
20498
1.60
85.79
4.3
3.2
u/l
32.9
36.0
1.28
2718
19276
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
3035
21883
1.59
85.31
3.3
2.6
u/l
54.3
59.4
4.35
2828
20136
(4015189)
129
190
6.87
83.19
2.9
2.0
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
706
3270
2.26
82.93
10.0
4.9
%
2.0
1.6
14.28
658
3071
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
251
675
3.80
80.62
2.3
1.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
262
726
3.69
80.56
2.3
1.6
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
549
2331
2.44
78.64
2.0
1.5
titre
145.3
239.1
0.88
32
110
(3042733) HLA Ab [Presence] in Serum
116
164
7.15
77.67
4.8
4.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
1170
6671
1.87
77.38
2.2
2.5
g/l
64.8
66.0
4.76
1052
5954
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
305
960
3.25
76.93
5.7
2.9
u/ml
1125.4
2002.7
0.49
22
68
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
77
65
11.94
76.30
3.4
1.5
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
463
1841
2.60
76.15
5.7
2.7
%
88.6
88.4
0.06
443
1738
(46235355) HIV 1 and 2 tests - Meaningful Use set
1274
7497
1.82
76.01
1.8
1.7
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
613
2782
2.29
75.40
8.7
3.7
mmol/l
1.3
1.4
1.52
599
2732
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1471
9056
1.75
75.17
3.8
4.0
u/l
262.3
248.4
2.38
1379
8460
(3028192) IgG subclass 2 [Mass/volume] in Serum
221
581
3.88
73.31
1.4
1.3
g/l
2.2
2.9
8.69
157
414
(3027135) IgG subclass 1 [Mass/volume] in Serum
220
581
3.86
72.51
1.4
1.3
g/l
6.3
7.0
1.17
153
410
(3024139) IgG subclass 3 [Mass/volume] in Serum
220
581
3.86
72.51
1.4
1.3
g/l
0.3
0.4
3.09
154
413
(4062490)
220
582
3.85
72.34
1.5
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
1282
7666
1.79
72.20
1.4
1.3
titre
465.6
513.9
0.52
298
1628
(3039000) Anion gap in Blood
429
1693
2.61
71.60
14.1
6.5
mmol/l
10.5
11.3
4.68
393
1516
(3018572) Chloride [Moles/volume] in Blood
429
1693
2.61
71.60
14.1
6.5
mmol/l
103.2
105.1
11.02
393
1516
(3026008) Bacteria identified in Urine by Culture
2998
22215
1.53
71.38
4.1
3.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
1037
5846
1.88
70.66
5.2
3.9
%
1.0
0.9
0.31
383
1780
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
2136
14700
1.60
70.43
6.2
4.1
ng/l
356.9
522.2
1.18
1861
12425
(3007930) Methemoglobin/Hemoglobin.total in Blood
668
3227
2.16
70.37
10.5
4.9
%
0.9
0.9
0.00
623
3033
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1776
11716
1.65
69.49
3.6
2.0
s
30.9
30.2
3.93
1721
11350
(3002179) Metamyelocytes/100 leukocytes in Blood
953
5266
1.91
68.99
5.0
3.8
%
0.8
0.6
0.74
298
1245
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
671
3273
2.14
68.91
2.8
1.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1971
13434
1.60
67.20
6.5
4.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
408
1624
2.59
66.87
1.5
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
2150
15049
1.57
65.06
3.7
2.9
mosm/kgh2o
517.5
557.3
17.74
1903
12787
(3018418) pH of Serum or Plasma
2867
21372
1.51
64.81
6.3
4.0
ph
7.4
7.4
0.27
758
4009
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
621
3014
2.14
64.49
2.5
1.8
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
411
1677
2.52
63.95
3.9
2.7
%
212.0
201.6
1.27
396
1597
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
362
1398
2.66
63.05
1.5
1.2
titre
57.1
211.7
1.01
14
29
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
2642
19465
1.51
62.73
2.8
2.3
mg/l
3.8
3.0
24.71
2271
16403
(3024980) IgG subclass 4 [Mass/volume] in Serum
277
935
3.03
62.04
1.5
1.6
g/l
0.6
0.9
3.12
204
708
(3021440) Promyelocytes/100 leukocytes in Blood
966
5554
1.83
61.34
5.3
4.0
%
0.1
0.1
0.10
367
1651
(3010375) cycloSPORINE [Mass/volume] in Blood
130
262
5.02
60.61
37.5
26.9
ug/l
138.7
115.2
2.30
102
219
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
1236
7667
1.71
60.31
6.4
3.6
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
330
1249
2.71
59.80
1.5
1.5
g/l
31.7
31.1
0.36
305
1105
(3025159) Blasts/100 leukocytes in Blood
906
5167
1.84
58.94
5.4
4.0
%
0.0
0.3
1.82
323
1369
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
510
2380
2.21
58.36
1.4
1.3
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
117
223
5.30
58.11
41.2
33.1
ug/l
8.1
7.3
2.69
99
204
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
293
1070
2.80
56.87
1.6
1.3
—
—
—
0
0
(3024471) HLA-A [Type]
100
169
5.97
56.46
1.0
1.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
205
614
3.39
56.01
1.9
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
205
614
3.39
56.01
1.9
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
205
614
3.39
56.01
1.9
1.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
168
444
3.84
55.36
2.0
2.3
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
128
277
4.67
54.86
8.6
6.3
mmol/l
27.0
24.7
4.80
119
246
(3011412) CD3 cells [#/volume] in Blood
198
590
3.41
54.54
2.3
2.5
e9/l
1.1
1.1
0.12
130
363
(40757373) Influenza virus identified in Isolate
90
143
6.35
54.05
2.3
1.4
—
—
—
0
0
(3036489) Thrombin time
490
2324
2.17
53.79
3.9
2.2
s
22.3
21.8
0.72
450
2079
(3023199) Leukocytes [#/volume] in Pleural fluid
291
1091
2.72
53.71
1.5
1.5
e6/l
4178.9
2106.8
0.90
237
779
(3024932) HLA-DR beta [Type]
96
164
5.91
53.62
1.0
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
405
1784
2.33
53.14
1.6
1.5
g/l
1.2
1.2
1.18
379
1685
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
395
1729
2.34
52.58
1.6
1.5
g/l
0.2
0.2
0.63
367
1635
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
424
1925
2.26
51.80
1.6
1.4
iu/ml
8.4
15.9
1.31
13
41
(3027945) Reticulocytes/100 erythrocytes in Blood
1432
9566
1.59
51.48
3.0
2.5
%
2.0
1.7
11.65
1256
8320
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
526
2613
2.08
51.15
1.8
1.7
u/l
36.3
38.3
1.46
461
2234
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2881
22278
1.44
50.89
3.1
2.2
u/l
259.0
227.1
0.42
2706
20767
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
5710
63800
0.70
50.69
5.2
5.2
mmol/l
2.4
2.6
39.41
5092
57657
(3004119) Hemoglobin [Mass/volume] in Venous blood
819
4763
1.79
49.58
5.7
3.6
g/l
126.2
127.6
0.97
780
4654
(3000850) Epithelial cells [#/volume] in Urine
2172
16009
1.47
49.09
3.7
2.7
e6/l
4.9
4.6
0.66
1963
14000
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
287
1119
2.62
49.01
1.7
1.4
u/ml
8.6
19.3
—
6
22
(3028308) Erythrocytes [#/volume] in Pleural fluid
264
988
2.72
48.90
1.5
1.5
e6/l
100576.3
59250.2
0.81
178
586
(40768806) Pleura Pathology biopsy report
255
943
2.75
48.33
1.6
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
917
5554
1.73
48.12
2.0
2.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
256
954
2.73
47.81
1.5
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
5486
61517
0.71
47.65
4.8
4.6
mmol/l
1.4
1.4
24.52
4870
55471
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
192
611
3.19
47.59
1.7
1.4
u/l
12.9
13.2
0.24
185
587
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
286
1130
2.58
47.54
1.7
1.4
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
699
3933
1.84
47.09
5.5
3.5
mmol/l
27.2
24.9
28.56
656
3819
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
259
982
2.69
46.77
1.8
1.5
u/ml
113.6
118.6
0.28
56
198
(1175426) CD3 cells/100 lymphocytes in Blood
162
471
3.48
46.40
2.0
2.3
%
73.0
70.6
0.92
150
443
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
158
458
3.49
45.47
2.0
2.3
%
11.6
13.9
1.22
83
199
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
5565
62107
0.72
45.44
4.8
4.6
mmol/l
4.3
4.5
31.65
4997
56421
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1188
7800
1.60
45.44
3.1
2.8
umol/l
7.8
9.3
2.54
1024
6762
(3035880) pH of Pleural fluid
165
494
3.38
45.16
1.3
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
327
1412
2.37
44.88
1.7
1.6
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
78
133
5.91
43.69
3.9
2.3
ml/dl
15.0
14.6
0.55
71
124
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
134
359
3.77
43.37
2.2
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
134
359
3.77
43.37
2.2
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
134
359
3.77
43.37
2.2
1.9
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
244
935
2.66
43.16
9.7
14.7
mmol/l
7.7
7.3
0.87
212
760
(3031040) Bacteria [#/volume] in Urine by Automated count
5260
45758
1.37
43.15
6.8
4.9
e6/l
1322.9
1750.9
0.16
98
783
(3043409) Potassium [Moles/volume] in Arterial blood
469
2376
2.03
43.14
10.1
3.9
mmol/l
4.0
3.9
1.89
427
2210
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
133
359
3.75
42.59
2.2
1.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
2553
19803
1.41
42.53
4.5
3.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
2291
17459
1.42
42.15
7.2
4.1
%
83.2
84.6
1.68
2232
17013
(3001964) Herpes simplex virus Ag [Presence] in Specimen
89
178
5.04
41.94
2.7
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
2863
22685
1.39
41.91
4.6
3.5
e6/l
171.1
100.8
0.76
2394
17721
(3017143) Hepatitis C virus Ab [Presence] in Serum
911
5713
1.66
41.69
1.9
1.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
345
1574
2.24
41.62
4.7
3.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
959
6118
1.64
40.99
6.4
3.8
mmol/l
1.2
1.2
6.77
884
5284
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
102
234
4.40
40.73
2.3
1.8
u/ml
467.5
69205.4
0.89
19
32
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
225
859
2.66
40.11
1.4
1.3
u/l
310.0
388.0
0.74
207
813
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
139
404
3.48
39.88
2.4
2.6
e6/l
502.3
500.8
0.01
106
333
(3030467) Casts [#/volume] in Urine by Automated count
2621
20630
1.38
39.37
4.5
3.4
e6/l
0.7
0.5
2.94
2170
15805
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
134
385
3.52
39.14
2.4
2.6
e9/l
0.2
0.2
1.20
109
333
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
206
763
2.74
38.97
3.0
3.0
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
343
1619
2.16
38.03
1.8
1.8
mg/l
11.4
12.0
0.45
321
1475
(3036782) Glucose [Moles/volume] in Pleural fluid
216
834
2.63
37.66
1.4
1.4
mmol/l
6.7
6.4
0.82
200
762
(3001122) Ferritin [Mass/volume] in Serum or Plasma
3326
27327
1.35
37.57
3.9
2.9
ug/l
169.0
151.9
1.81
3039
24769
(3045788) Cell count panel - Pleural fluid
218
847
2.61
37.54
1.5
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
973
6422
1.58
35.86
1.9
1.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
5853
52427
1.35
35.84
11.5
7.5
u/l
84.1
81.2
2.89
5631
48983
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
150
489
3.10
35.78
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
153
507
3.05
35.49
2.4
2.4
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
94
226
4.19
35.37
2.4
2.6
%
11.7
12.0
0.05
86
205
(3023520) Reticulocytes [#/volume] in Blood
1065
7197
1.55
35.33
3.1
2.5
e9/l
75.3
67.7
8.52
835
5469
(3019309) Folate [Moles/volume] in Red Blood Cells
2075
15953
1.39
35.14
2.0
1.8
nmol/l
1208.9
1159.2
1.44
1552
11843
(3021589) Normoblasts [#/volume] in Blood
3469
28882
1.33
35.07
17.7
10.1
e9/l
0.0
0.0
0.87
2905
23425
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
106
282
3.79
34.72
2.3
2.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
877
5693
1.60
34.63
5.9
4.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
133
412
3.26
34.55
2.7
1.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
5698
62558
0.75
34.55
5.4
4.9
mmol/l
6.2
6.1
12.95
5072
55812
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
105
280
3.78
34.28
2.3
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
105
280
3.78
34.28
2.3
2.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
1076
7337
1.53
34.19
2.9
2.4
ug/l
8.1
7.0
0.90
912
6225
(3007164) IgA [Mass/volume] in Serum or Plasma
1493
10877
1.45
34.14
1.8
1.5
g/l
2.7
2.6
1.05
990
6330
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
368
1866
2.01
33.72
5.3
4.0
mg/l
1.9
1.6
4.97
330
1677
(3003181) Sodium [Moles/volume] in Urine
290
1344
2.20
33.68
1.6
1.4
mmol/l
63.0
62.7
0.03
219
1080
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
177
655
2.74
33.59
1.4
1.3
u/l
14.3
13.2
0.17
156
601
(3008536) Aspergillus sp Ab [Presence] in Serum
67
127
5.31
33.59
2.1
2.0
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
186
709
2.66
33.31
1.3
1.1
%
115.6
114.5
0.16
173
622
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
857
5609
1.58
32.60
5.2
3.8
ng/l
121.8
96.2
4.48
717
4743
(4306422)
188
729
2.61
32.54
1.4
1.2
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
89
219
4.09
32.50
2.1
2.5
%
31.2
29.1
0.49
81
203
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
194
776
2.53
31.52
1.1
1.1
g/l
1.6
1.5
0.48
177
694
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
153
545
2.84
31.23
1.3
1.1
%
89.7
95.5
1.85
147
505
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
226
974
2.35
31.21
1.4
1.3
u/ml
297.3
273.5
0.56
163
584
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
238
1050
2.30
31.14
1.4
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
193
775
2.52
31.11
1.4
1.2
u/ml
4.3
4.2
0.05
90
339
(3048929) Epstein Barr virus Ab [Presence] in Serum
296
1427
2.11
31.10
1.4
1.3
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
602
3652
1.70
30.96
6.2
4.2
%
50.7
47.6
2.36
584
3608
(40758558) Short blood count panel - Blood
2145
16888
1.36
30.62
9.5
6.6
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
360
1874
1.96
30.61
3.4
3.1
nmol/l
0.9
0.8
1.27
286
1412
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
5411
59498
0.77
30.48
4.5
4.1
mmol/l
1.4
1.3
25.53
4796
53146
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
188
753
2.53
30.47
1.2
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
195
796
2.48
30.36
1.4
1.2
u/ml
4.6
3.6
0.22
65
263
(3018095) Leukocytes [#/volume] in Urine
3083
25614
1.31
30.31
5.3
4.0
e6/l
108.0
115.7
0.17
2480
18840
(3003338) MCHC [Mass/volume]
4700
52479
0.78
28.89
42.5
21.8
g/l
327.6
331.9
133.59
4631
51873
(21494815) CD4 cells/100 lymphocytes in Specimen
143
513
2.82
28.84
2.1
2.4
%
35.2
41.2
0.54
13
54
(3022217) INR in Platelet poor plasma by Coagulation assay
1521
11422
1.40
28.84
30.8
29.6
inr
1.7
1.5
3.46
180
1564
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
232
1055
2.23
28.27
1.6
1.9
ug/l
27.8
23.1
0.36
222
1029
(3000060) B lymphocytes [#/volume] in Blood
70
162
4.35
27.75
2.2
2.7
e6/l
217.2
1000.8
0.92
36
84
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
3191
26889
1.29
27.44
2.9
2.2
nmol/l
76.7
78.4
2.54
2817
23506
(3023383) Lactate [Moles/volume] in Pleural fluid
96
281
3.44
27.37
1.3
1.3
mmol/l
3.4
3.6
0.30
88
254
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
77
198
3.91
26.55
1.5
1.2
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
30
30
10.03
26.47
1.3
1.1
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
580
3632
1.64
26.33
4.9
2.9
%
0.6
0.7
0.40
564
3491
(3015171) Extractable nuclear Ab [Units/volume] in Serum
381
2123
1.83
26.30
1.3
1.2
u/ml
2.0
1.0
0.43
28
202
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1955
24246
0.75
26.13
4.1
4.6
%
21.4
22.3
1.42
925
12682
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
51
95
5.39
26.11
1.2
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
62
137
4.55
26.06
1.3
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
2685
22239
1.30
25.98
3.6
2.6
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
107
348
3.10
25.74
2.7
2.2
mmol/l
8.1
9.4
3.11
87
270
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
151
591
2.58
25.73
1.2
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
619
3963
1.60
25.67
1.8
1.6
g/l
1.7
1.5
4.26
516
3350
(3004809) Band form neutrophils/100 leukocytes in Blood
264
1313
2.04
25.57
3.8
3.5
%
1.2
1.6
0.97
218
978
(3021879) Hepatitis B virus core Ab [Presence] in Serum
580
3662
1.62
25.46
1.5
1.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
66
157
4.23
25.28
1.2
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
82
229
3.60
25.13
1.2
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
2281
18578
1.31
24.79
4.3
2.9
umol/l
4393.8
5517.0
0.59
1973
15768
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
67
164
4.11
24.72
1.2
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
135
520
2.62
23.80
1.2
1.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
446
2683
1.70
23.61
2.7
3.1
mg/l
134.3
85.5
0.28
336
2184
(3037756) Immunofixation for Serum or Plasma
326
1795
1.85
23.40
1.3
1.5
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
47
90
5.24
23.37
1.4
1.2
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
92
290
3.20
23.36
1.5
1.4
%
3.3
2.6
0.27
75
236
(3009466) Valproate [Moles/volume] in Serum or Plasma
197
907
2.20
23.35
5.9
4.4
umol/l
355.6
348.0
0.34
171
760
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
29
33
8.81
23.27
1.4
1.4
mg/l
3.7
3.8
0.02
20
17
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
29
33
8.81
23.27
1.4
1.4
mg/l
0.8
0.6
0.28
17
19
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
29
33
8.81
23.27
1.4
1.4
mg/l
3.3
0.6
0.86
18
19
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
29
33
8.81
23.27
1.4
1.4
mg/l
2.0
1.3
0.20
14
17
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
29
33
8.81
23.27
1.4
1.4
mg/l
3.6
1.8
0.62
19
21
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
29
33
8.81
23.27
1.4
1.4
mg/l
5.4
2.2
0.95
17
19
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
29
33
8.81
23.27
1.4
1.4
mg/l
1.5
2.3
0.29
19
22
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
29
33
8.81
23.27
1.4
1.4
mg/l
4.7
1.5
0.98
21
21
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
29
33
8.81
23.27
1.4
1.4
mg/l
1.6
1.0
0.18
18
18
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
444
2679
1.69
23.24
2.7
3.1
mg/l
40.6
52.7
1.14
332
2179
(3037467) Urinalysis macro (dipstick) panel - Urine
5165
46682
1.26
23.22
6.5
4.6
—
—
—
0
0
(4268621)
133
515
2.61
23.21
2.5
2.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
65
164
3.99
23.05
6.9
2.1
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
26
26
10.03
22.92
1.2
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
68
178
3.84
22.92
1.3
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
433
2608
1.69
22.82
2.7
3.0
ratio
6.2
2.4
0.51
36
200
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
857
6037
1.46
22.75
1.8
1.7
%
1.6
1.5
2.49
719
5152
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
29
34
8.55
22.74
1.4
1.4
mg/l
2.5
1.5
0.29
18
20
(3015377) Calcium [Moles/volume] in Serum or Plasma
2844
24043
1.27
22.63
3.9
3.3
mmol/l
2.3
2.3
8.59
2435
20508
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
61
149
4.12
22.60
1.6
1.5
ug/l
0.3
0.4
0.51
39
84
(3010503) CD19 cells [#/volume] in Blood
108
383
2.84
22.35
2.4
2.4
e9/l
0.1
0.2
0.69
102
365
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
111
400
2.80
22.30
3.2
2.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
351
2015
1.77
21.96
2.7
3.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
153
653
2.37
21.72
1.3
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
6692
70771
0.77
21.69
47.5
24.4
e9/l
7.8
6.9
116.53
6501
68244
(3008757) Leukocyte morphology finding [Identifier] in Blood
184
850
2.19
21.66
3.8
4.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
80
243
3.31
21.60
1.9
2.2
umol/l
135.9
134.0
0.02
34
137
(3000963) Hemoglobin [Mass/volume] in Blood
6693
70765
0.78
21.52
48.0
24.5
g/l
130.5
133.7
43.62
6573
69386
(3026361) Erythrocytes [#/volume] in Blood
6692
70751
0.78
21.46
47.4
24.3
e12/l
4.4
4.4
4.82
6501
68219
(3035941) MCH [Entitic mass]
6692
70747
0.78
21.42
47.2
24.2
pg
30.0
30.4
43.11
6579
69356
(3024731) MCV [Entitic volume]
6692
70747
0.78
21.42
47.3
24.2
fl
91.7
91.5
3.05
6580
69356
(3051651) Icteric interference index of Serum or Plasma
115
432
2.68
21.35
5.1
3.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
6691
70725
0.78
21.27
47.5
24.3
e9/l
250.0
240.8
20.01
6526
68463
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
122
474
2.60
21.18
1.2
1.2
titre
270.0
205.6
—
6
16
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
122
474
2.60
21.18
1.2
1.2
titre
151.3
160.7
0.04
16
90
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
131
530
2.49
20.92
1.6
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
94
321
2.95
20.86
1.1
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
374
2219
1.72
20.84
4.7
3.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1531
19113
0.76
20.36
3.2
3.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
231
1192
1.96
20.24
5.1
3.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1351
17140
0.75
20.14
2.8
3.2
ug/l
0.8
0.8
0.95
914
12135
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
72
215
3.37
20.00
1.6
1.4
%
24.9
23.4
0.14
62
170
(3020191) Ethanol [Moles/volume] in Serum or Plasma
118
465
2.56
19.93
1.7
1.3
promille
1.1
1.2
0.13
85
361
(3014271) Vancomycin [Susceptibility]
124
502
2.49
19.80
3.5
3.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
131
545
2.42
19.73
1.6
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
105
396
2.67
19.39
1.5
1.2
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
97
352
2.78
19.29
1.6
1.4
%
60.5
66.3
0.84
80
274
(44786800) Granulocytes/100 leukocytes in Body fluid
49
115
4.28
19.17
1.3
1.4
%
27.1
21.2
0.54
39
82
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
55
141
3.92
19.14
1.5
1.5
%
6.6
8.7
0.28
31
65
(3008295) Osmolality of Serum or Plasma
159
735
2.18
18.75
1.4
1.4
mosm/kgh2o
275.9
278.8
0.67
122
546
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
459
2951
1.59
18.66
2.0
2.3
g/l
10.1
10.3
0.24
374
2454
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
45
101
4.47
18.63
1.3
1.4
ng/l
153.9
901.3
0.47
33
69
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
189
3599
0.51
18.37
1.8
1.8
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
84
293
2.88
18.00
1.7
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
483
3168
1.55
18.00
2.1
2.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
482
3162
1.55
17.95
2.1
2.2
g/l
3.8
3.8
0.09
336
2219
(40768797) Stomach Pathology biopsy report
1173
9057
1.34
17.92
1.3
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
5308
48759
1.22
17.91
6.4
4.1
mm/h
18.1
13.8
49.65
4985
44468
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
483
3172
1.55
17.90
2.1
2.2
g/l
7.8
7.4
3.05
343
2303
(3013005) Retinol [Moles/volume] in Serum or Plasma
71
226
3.16
17.84
1.7
1.9
umol/l
2.0
1.9
0.36
66
212
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
131
572
2.31
17.74
1.5
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1936
16024
1.27
17.49
1.8
1.7
pmol/l
18734464.9
26720165.4
0.36
1564
12938
(21494755) Public health laboratory ask at order entry panel
170
3290
0.51
17.38
1.3
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
2633
30369
0.81
17.28
4.5
5.3
ug/l
3.5
4.2
0.76
2232
26870
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
299
1759
1.72
17.23
1.5
1.6
iu/ml
0.5
12.2
1.71
79
422
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
2029
16917
1.26
17.18
3.5
2.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
326
1969
1.68
17.05
1.6
1.6
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
42
96
4.39
17.02
1.5
1.4
%
78.2
72.1
0.62
33
79
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
96
371
2.60
16.94
1.6
1.4
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
31
55
5.65
16.76
1.5
1.5
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
412
2650
1.58
16.73
2.1
2.3
g/l
0.9
1.1
0.18
342
2223
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
447
2930
1.55
16.72
2.2
2.3
g/l
3.3
3.1
3.97
337
2261
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
5609
59982
0.82
16.49
7.6
6.4
mmol/mol
43.2
40.7
51.19
5082
54510
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
95
371
2.58
16.43
1.6
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
67
218
3.09
16.26
1.8
2.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
92
356
2.60
16.21
1.4
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
262
1519
1.75
15.92
1.6
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
3551
31583
1.21
15.90
5.8
4.3
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
90
348
2.60
15.89
1.1
1.1
nmol/l
4.3
11.3
0.77
22
80
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
293
1755
1.69
15.83
2.0
1.7
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
381
2439
1.59
15.80
2.0
2.2
g/l
36.4
37.2
1.59
323
2044
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
103
427
2.43
15.72
2.5
2.4
e6/l
531.8
586.7
0.26
39
167
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
6479
68185
0.81
15.55
16.4
10.8
u/l
25.8
25.7
0.07
6296
65167
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
67
225
2.99
15.42
1.1
1.1
u/ml
6.8
7.9
—
6
20
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
88
342
2.59
15.40
2.2
2.7
%
41.0
36.7
0.90
45
119
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
80
297
2.71
15.32
1.2
1.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
85
326
2.62
15.28
2.0
2.4
ml
1725.4
1878.9
0.58
72
275
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1469
11974
1.27
14.77
3.9
3.2
e6/l
2.6
2.0
1.58
892
6812
(3000919) Neutrophils/100 leukocytes in Pleural fluid
72
258
2.81
14.76
1.5
1.4
%
19.8
20.4
0.07
63
229
(3034770) Mitochondria Ab [Titer] in Serum
265
1576
1.70
14.73
1.2
1.2
titre
1530.0
920.6
—
5
47
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
58
184
3.17
14.72
7.8
8.3
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
27
48
5.64
14.58
1.1
1.1
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
339
2153
1.60
14.56
2.1
2.3
g/l
0.0
0.0
1.04
304
1938
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
484
3324
1.48
14.54
3.1
3.2
pmol/l
4.2
4.4
3.06
423
2898
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1217
9707
1.29
14.52
1.3
1.3
iu/ml
26.8
37.2
3.51
401
2926
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
359
2313
1.58
14.51
2.0
2.3
g/l
0.0
0.1
0.20
323
2089
(3042010) Triglyceride [Moles/volume] in Pleural fluid
44
118
3.74
14.45
1.3
1.3
mmol/l
0.6
1.6
0.86
26
80
(3026389) Candida sp identified in Specimen by Organism specific culture
159
815
1.97
14.33
1.5
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
834
6322
1.35
14.26
2.8
2.4
u/l
31.1
46.0
1.25
712
5364
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
333
2119
1.59
14.20
2.1
2.3
g/l
0.0
0.0
0.00
302
1932
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
68
242
2.82
14.14
3.9
2.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
68
242
2.82
14.14
3.9
2.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
47
134
3.52
14.12
1.4
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
388
2570
1.53
13.87
3.4
3.1
g/l
0.4
0.4
0.13
182
1128
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
214
1220
1.77
13.84
1.2
1.2
u/ml
14.5
9.6
—
7
12
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
41
109
3.77
13.65
1.2
1.3
u/l
215.6
343.6
0.17
26
78
(3041096) Erythrocytes [Presence] in Urine by Automated
2005
17061
1.23
13.59
5.0
3.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
210
1198
1.77
13.56
1.6
1.5
—
—
—
0
0
(3014891) Appearance of Pleural fluid
46
133
3.47
13.55
1.8
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
113
521
2.18
13.54
3.2
2.8
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
65
233
2.80
13.36
1.4
2.0
ug/l
24.9
271.2
0.93
65
212
(21494814) CD8 cells/100 lymphocytes in Specimen
68
250
2.73
13.33
1.8
2.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
152
788
1.95
13.29
3.4
3.4
%
66.0
58.9
3.47
111
473
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
117
2334
0.49
13.18
1.5
1.5
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
55
185
2.99
12.69
1.1
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
484
3419
1.44
12.58
1.4
1.3
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
49
155
3.17
12.55
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
49
155
3.17
12.55
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
49
155
3.17
12.55
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
49
155
3.17
12.55
1.1
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
245
1491
1.66
12.55
1.7
1.4
mg/l
497.8
556.2
1.34
231
1398
(3038071) Oxygen [Partial pressure] in Mixed venous blood
49
156
3.15
12.42
7.8
8.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
162
878
1.86
12.41
1.8
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
162
878
1.86
12.41
1.8
1.4
—
—
—
0
0
(3013512) EKG study
2439
21316
1.20
12.35
5.8
4.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
162
881
1.85
12.29
1.8
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
84
359
2.35
12.09
1.0
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
219
1307
1.69
12.09
1.5
1.4
mmol/l
4.0
3.8
1.40
200
1216
(3041918) Cholesterol [Moles/volume] in Pleural fluid
49
159
3.09
12.04
1.2
1.2
mmol/l
1.3
1.5
0.66
28
101
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
209
1233
1.71
12.04
1.3
1.2
u/l
44.8
42.0
0.09
164
1061
(3007566) Smooth muscle Ab [Titer] in Serum
253
1575
1.62
11.87
1.2
1.2
titre
207.4
88.1
1.18
23
120
(3052592) Norovirus Ag [Presence] in Stool
51
171
2.99
11.86
1.9
1.3
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
90
400
2.26
11.85
1.6
1.9
u/field
2.0
2.6
0.36
67
272
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
121
604
2.02
11.84
1.5
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
222
1338
1.68
11.82
1.1
1.1
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
21
36
5.84
11.78
2.6
3.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
184
1054
1.76
11.78
1.2
1.3
miu/ml
199.6
213.6
0.16
42
409
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
4317
39712
1.17
11.70
4.7
3.1
u/l
65.5
53.5
9.36
4001
36213
(3019225) pH of Specimen
941
7458
1.29
11.67
6.4
4.4
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
14
15
9.35
11.65
1.1
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
90
404
2.24
11.58
2.7
2.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
2087
18068
1.20
11.58
5.4
4.3
estimate
0.0
0.0
0.18
882
5752
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
81
348
2.34
11.54
1.5
1.5
u/l
8.1
6.2
0.45
67
289
(4198724)
47
153
3.08
11.51
2.8
3.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
224
1365
1.66
11.45
1.3
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1392
16576
0.81
11.37
1.7
1.6
mmol/l
1.5
1.3
8.67
1159
13737
(3016038) Potassium [Moles/volume] in Urine
103
496
2.09
11.13
1.6
1.2
mmol/l
30.1
35.3
1.53
82
417
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
161
904
1.80
11.05
1.8
1.4
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
78
337
2.33
11.00
1.3
1.1
iu/ml
5.2
3.5
—
6
16
(3032743) Legionella sp IgG Ab [Presence] in Serum
20
35
5.72
10.99
1.2
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
20
35
5.72
10.99
1.2
1.1
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
67
271
2.48
10.92
1.4
1.3
ug/l
252.6
394.7
0.32
40
141
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
67
271
2.48
10.92
2.2
2.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
153
853
1.81
10.77
1.2
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
137
739
1.87
10.72
1.1
1.1
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
17
26
6.55
10.62
6.9
9.4
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
14
17
8.25
10.60
1.1
1.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
157
889
1.78
10.50
1.8
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
156
883
1.78
10.45
1.8
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
156
885
1.78
10.38
1.1
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
144
798
1.82
10.35
1.5
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
583
4394
1.35
10.33
3.8
3.2
e9/l
4.8
4.2
4.43
418
3184
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
69
291
2.38
10.30
1.2
1.2
ratio
1.1
1.1
0.40
31
94
(3022493) Free Hemoglobin [Mass/volume] in Plasma
73
318
2.31
10.13
4.9
4.0
mg/l
69.4
66.4
0.14
51
224
(3004616) Nuclear Ab [Presence] in Serum
134
735
1.84
9.98
1.4
1.3
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
56
218
2.58
9.91
2.4
2.0
e6/l
46233.6
17357.2
0.75
28
125
(40759836) Histone Ab [Presence] in Serum by Immunoblot
84
392
2.15
9.89
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
84
392
2.15
9.89
1.2
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
46
162
2.85
9.87
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
84
393
2.15
9.83
1.2
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
232
1484
1.58
9.80
1.4
1.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
193
1184
1.64
9.68
1.3
1.2
u/ml
11.7
4.6
0.33
19
83
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
84
396
2.13
9.65
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
84
396
2.13
9.65
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
84
396
2.13
9.65
1.2
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
83
394
2.12
9.38
1.1
1.2
mg/l
75.5
45.1
0.54
65
325
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
27
70
3.87
9.38
3.2
3.0
mg/l
1.3
1.5
0.21
19
53
(3009508) Creatinine [Moles/volume] in Urine
2506
22385
1.17
9.25
3.6
3.2
mmol/l
6.9
7.4
7.56
2059
18405
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
179
1092
1.65
9.20
1.3
1.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
205
1294
1.60
9.18
1.6
1.5
e6/l
12.3
22.2
0.72
157
983
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
205
1295
1.60
9.16
1.7
1.6
e6/l
1182.7
904.3
0.16
169
1043
(3051611) Lipemic interference index of Serum or Plasma
138
785
1.77
9.15
5.0
3.4
—
—
—
0
0
(4027681)
65
282
2.31
9.15
1.3
1.2
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
19
38
5.01
9.08
1.3
1.0
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
30
86
3.50
9.04
1.2
1.2
mg/l
11.4
6.8
1.19
30
79
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
79
374
2.12
9.01
1.0
1.1
mg/l
408.9
297.4
0.53
66
326
(3021960) Folate [Moles/volume] in Serum or Plasma
2029
17855
1.18
8.99
1.8
1.6
nmol/l
19.7
20.0
0.28
1744
15148
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
111
597
1.87
8.85
1.1
1.1
—
3.5
—
0
9
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
156
931
1.69
8.74
1.1
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
232
1525
1.54
8.73
1.3
1.2
u/ml
55.0
42.5
0.28
17
75
(3027923) C peptide [Moles/volume] in Serum or Plasma
75
354
2.13
8.64
1.2
1.3
nmol/l
1.4
1.2
0.67
53
269
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
220
1433
1.55
8.63
1.4
1.2
u/ml
5.0
6.7
0.47
43
220
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
51
204
2.51
8.59
1.0
1.1
%
100.3
92.6
1.03
39
150
(3000570) Elastase.pancreatic [Mass/mass] in Stool
291
2012
1.46
8.57
1.5
1.4
ug/g
270.0
267.2
0.08
181
1209
(3012516) Albumin [Mass/volume] in Urine
2418
21651
1.16
8.51
3.6
3.2
mg/l
665.1
345.6
2.12
1690
13969
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
147
870
1.70
8.51
1.5
1.5
%
56.6
62.0
0.81
95
567
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1478
12712
1.20
8.50
3.7
3.0
e6/l
1.1
1.3
0.42
909
7491
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
124
701
1.78
8.43
1.3
1.2
u/l
102.7
68.1
0.40
83
466
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
5736
60072
0.87
8.41
29.7
15.8
ml/min/173m2
75.9
74.7
2.77
5029
49763
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
217
1418
1.54
8.41
1.4
1.2
u/ml
11.8
5.2
0.32
32
136
(3039443) Prostate specific Ag panel - Serum or Plasma
50
1142
0.43
8.35
1.4
1.6
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
33
107
3.09
8.22
14.5
13.1
mmol/l
5.6
5.4
0.13
33
107
(3023487) Leukocytes [#/volume] in Peritoneal fluid
57
246
2.33
8.16
2.6
2.2
e6/l
11746.7
4316.6
0.29
38
172
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
42
157
2.68
8.12
1.1
1.3
%
83.0
82.2
0.04
28
83
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
18
38
4.74
8.10
2.3
3.9
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
34
114
2.99
8.01
2.0
1.9
—
—
—
0
0
(3011648) Oxygen content in Venous blood
102
553
1.85
7.98
5.6
3.7
%
10.7
11.0
0.28
102
553
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
94
497
1.90
7.94
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
282
1970
1.45
7.90
1.4
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
121
694
1.75
7.87
1.1
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
35
122
2.88
7.72
1.1
1.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
92
489
1.89
7.66
1.4
1.2
mmol/l
2.2
2.1
0.31
83
457
(3032057) Clostridioides difficile [Presence] in Stool
47
192
2.46
7.62
1.8
1.9
—
—
—
0
0
(3016750) Collection duration of Urine
84
434
1.94
7.62
2.0
2.0
min
505.5
495.7
0.30
49
303
(3025549) Creatine [Moles/time] in 24 hour Urine
20
50
4.01
7.33
1.4
1.4
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
71
352
2.03
7.25
1.2
1.1
u/l
32.6
30.2
0.13
52
259
(3021788) Differential panel - Synovial fluid
192
1264
1.53
7.25
1.5
1.5
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
40
155
2.59
7.25
1.1
1.2
%
83.7
83.6
0.00
27
80
(3013336) Amino acids [Identifier] in Serum or Plasma
12
19
6.32
7.24
3.5
1.7
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
71
353
2.02
7.20
1.2
1.1
u/l
103.2
88.9
0.53
55
266
(3016018) Differential panel - Cerebral spinal fluid
110
632
1.75
7.15
1.8
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
3521
32641
1.13
7.12
5.0
3.9
estimate
0.0
0.0
0.50
953
6020
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
26
81
3.22
6.95
1.1
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
121
722
1.69
6.88
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
228
1573
1.46
6.88
1.3
1.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
33
119
2.78
6.88
1.8
1.6
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
51
228
2.24
6.80
2.4
1.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
2521
22940
1.14
6.75
4.4
4.0
mg/mmol
18.6
10.5
5.70
1713
14608
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
75
390
1.93
6.73
1.4
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
75
390
1.93
6.73
1.4
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
944
7960
1.21
6.66
3.0
3.9
ug/l
18.1
24.4
0.48
790
6608
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
151
964
1.58
6.58
2.7
2.1
mg/l
23.1
25.4
0.27
39
226
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
3294
30535
1.13
6.49
2.3
2.1
pmol/l
90.2
92.9
2.72
1893
16085
(40768800) Prostate Pathology biopsy report
121
1939
0.62
6.46
1.1
1.2
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
14
29
4.83
6.44
4.0
5.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
3550
33076
1.12
6.38
5.0
4.0
estimate
0.0
0.0
2.20
913
5928
(3044007) Cell count panel - Peritoneal fluid
45
197
2.29
6.33
3.0
1.9
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
27
92
2.94
6.25
1.3
1.2
u/l
16.8
19.5
0.40
21
63
(40768446) Kidney Pathology biopsy report
50
231
2.17
6.19
1.9
1.6
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
17
43
3.96
6.16
1.2
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
85
475
1.80
6.13
1.1
1.1
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
42
182
2.31
6.06
1.4
1.6
g/l
16.0
13.8
1.02
35
142
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
41
176
2.34
6.04
3.2
2.7
—
—
—
0
0
(4035726)
728
6049
1.22
5.97
1.5
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
6423
66305
0.88
5.93
32.2
15.9
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
115
1820
0.63
5.86
1.6
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
487
6067
0.79
5.85
1.5
1.4
—
—
—
0
0
(44806071)
21
64
3.29
5.84
1.1
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
36
148
2.44
5.84
1.5
1.3
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
58
291
2.00
5.81
1.4
1.3
%
29.1
64.5
—
7
33
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
19
55
3.46
5.72
1.3
1.4
ml/s/173m2
0.8
1.1
0.64
11
35
(3011288) Drugs identified in Urine by Screen method
119
745
1.61
5.69
4.3
3.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
110
676
1.64
5.67
1.4
1.2
u/ml
61.4
47.5
0.25
14
35
(3009214) Lutropin [Units/volume] in Serum or Plasma
180
1236
1.47
5.64
1.5
1.5
u/l
10.1
9.8
0.11
143
989
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
132
850
1.56
5.61
2.4
2.0
u/l
3601.5
3453.5
0.02
41
322
(3021601) Nitrite [Presence] in Urine by Test strip
3491
32669
1.11
5.56
6.5
5.2
estimate
0.0
0.0
0.50
939
6105
(3004775) Volume in Urine collected for unspecified duration
103
627
1.65
5.52
2.1
2.2
ml
571.1
654.0
1.21
59
395
(44816559) Phosphatidylethanol [Mass/volume] in Blood
143
941
1.53
5.52
1.5
1.3
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
23
79
2.92
5.29
1.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
77
441
1.75
5.18
1.4
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
133
876
1.53
5.14
3.2
2.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
155
1056
1.48
5.10
1.4
1.2
u/ml
56.3
46.4
0.34
23
113
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
21
70
3.00
5.09
1.0
1.0
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
20
65
3.08
5.05
1.1
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
58
307
1.90
5.04
1.2
1.3
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
37
166
2.23
4.99
1.4
1.3
%
109.5
111.7
0.15
31
146
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
82
484
1.70
4.98
1.2
1.2
u/ml
129.7
76.5
—
6
15
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
27
105
2.58
4.95
1.9
1.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
117
756
1.55
4.95
1.3
1.3
nmol/l
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
82
488
1.69
4.84
1.2
1.2
u/ml
37.3
37.7
—
6
34
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
43
208
2.07
4.82
1.2
1.2
—
—
—
0
0
(3018738) Hemoglobin F/Hemoglobin.total in Blood
14
37
3.79
4.80
4.4
4.5
%
17.0
6.1
—
5
14
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
54
284
1.91
4.80
1.0
1.1
u/l
1.0
1.1
2.13
25
137
(3038026) Centromere Ab [Units/volume] in Serum
83
497
1.68
4.79
1.2
1.2
u/ml
27.8
55.6
—
7
19
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
178
1261
1.42
4.79
2.3
1.7
nmol/l
1.0
0.8
2.31
151
1041
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
3577
33702
1.10
4.77
3.3
2.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
2700
25081
1.11
4.75
5.3
4.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
75
439
1.71
4.71
1.2
1.2
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
12
29
4.14
4.62
9.3
8.9
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
72
420
1.72
4.59
1.5
1.5
u/l
8.9
6.3
0.55
37
192
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
94
590
1.60
4.53
1.3
1.3
nmol/l
1.5
1.5
0.04
80
525
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
145
1002
1.45
4.49
1.3
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
149
1036
1.45
4.47
3.1
2.2
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
26
105
2.48
4.45
1.2
1.2
%
84.3
78.3
—
9
37
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
20
71
2.82
4.38
1.9
1.5
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
103
667
1.55
4.36
1.1
1.1
u/ml
6.4
4.4
0.35
51
350
(3011985) Renin [Units/volume] in Plasma
123
829
1.49
4.33
1.3
1.4
mu/l
89.8
64.9
0.50
110
724
(3000475) Leukocytes [#/volume] in Synovial fluid
231
1739
1.34
4.33
1.5
1.6
e6/l
18708.4
14449.0
0.32
175
1245
(3023410) Appearance of Cerebral spinal fluid
90
566
1.60
4.33
2.0
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
157
1110
1.42
4.32
3.1
2.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
250
1905
1.32
4.31
2.4
2.3
ug/min
197.2
109.2
1.32
144
1092
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
42
211
2.00
4.29
1.0
1.1
u/ml
5.8
4.6
0.17
16
29
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
26
107
2.43
4.28
1.2
1.2
%
62.1
76.4
—
9
37
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
5663
58515
0.91
4.27
5.3
4.6
mu/l
2.0
2.1
1.80
5127
52387
(3000093) Morphology [Interpretation] in Blood Narrative
115
768
1.50
4.24
1.3
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1359
12210
1.13
4.24
1.3
1.3
u/ml
1.6
1.9
0.50
315
3077
(3044941) Cell count panel - Synovial fluid
156
1106
1.42
4.23
1.3
1.4
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
46
241
1.91
4.18
1.2
1.2
g/l
37.6
40.5
0.62
23
121
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
21
79
2.66
4.14
4.4
4.6
ug/min
48.1
53.1
0.12
16
65
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
58
329
1.77
4.11
1.1
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
38
188
2.03
4.07
1.2
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
99
647
1.54
4.06
1.1
1.1
u/ml
0.6
1.2
1.25
40
305
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1026
9075
1.15
4.05
1.3
1.2
u/ml
14.8
13.3
0.11
348
3247
(3023103) Potassium [Moles/volume] in Serum or Plasma
6630
67929
0.90
4.05
41.9
19.9
mmol/l
4.0
4.0
9.37
6474
65930
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
28
123
2.28
4.02
8.4
8.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
115
778
1.48
4.01
1.4
1.3
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
103
683
1.51
3.96
1.7
2.2
u/field
1.7
1.7
0.05
56
242
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
124
855
1.46
3.94
1.4
1.3
nmol/l
0.6
1.9
0.50
116
819
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
29
131
2.22
3.91
1.3
1.2
mg/l
146.3
92.7
0.13
22
97
(3020393) Adenovirus Ag [Presence] in Stool
23
94
2.45
3.87
1.9
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
73
451
1.62
3.82
1.3
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
5503
56816
0.92
3.80
35.2
17.9
%
38.3
38.9
3.94
3268
36750
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
24
101
2.38
3.80
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
348
2814
1.25
3.80
1.6
1.6
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
31
146
2.13
3.79
1.3
1.2
pmol/l
298.7
263.4
0.37
23
104
(3024869) Neuronal Ab [Presence] in Serum
29
133
2.18
3.78
1.0
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
91
594
1.54
3.78
1.1
1.1
u/ml
2.2
2.1
0.03
22
159
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
114
782
1.46
3.74
1.3
1.3
pmol/l
319.1
285.2
0.38
93
586
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
123
858
1.44
3.70
1.4
1.3
nmol/l
0.2
0.3
—
9
60
(3042517) Benzodiazepines panel - Urine
10
25
4.00
3.69
4.5
2.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
825
7241
1.15
3.65
1.3
1.3
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
30
142
2.12
3.63
1.3
1.3
mu/l
123.6
60.4
0.79
24
103
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
12
35
3.43
3.61
1.3
1.2
u/field
1.2
1.3
—
5
18
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
58
344
1.69
3.57
1.5
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
6628
67795
0.91
3.56
41.9
19.7
mmol/l
139.2
139.6
24.72
6482
65907
(36660697) Celiac disease serology panel - Serum
516
4372
1.19
3.55
1.2
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
110
758
1.46
3.54
1.1
1.1
u/ml
0.9
1.9
0.69
45
333
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
35
178
1.97
3.52
1.4
1.3
g/l
0.3
0.3
1.13
30
142
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
9
17
5.30
3.50
15.4
8.5
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
67
415
1.62
3.50
2.3
2.4
umol/l
52.0
36.3
0.28
12
43
(3017509) Phencyclidine [Presence] in Urine
11
31
3.55
3.48
1.3
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
56
332
1.69
3.46
1.7
1.4
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
21
87
2.42
3.46
1.0
1.2
nmol/l
5.4
385515.5
0.72
16
69
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
19
75
2.54
3.45
1.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
153
1125
1.37
3.43
3.2
2.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
57
341
1.68
3.41
1.5
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
152
1119
1.36
3.38
3.1
2.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
22
95
2.32
3.32
1.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
36
189
1.91
3.32
1.1
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
63
391
1.62
3.29
4.7
3.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
118
837
1.42
3.28
1.3
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
179
1359
1.32
3.26
1.6
1.5
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
6
7
8.58
3.26
1.7
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
19
78
2.44
3.20
1.1
1.1
—
—
—
0
0
(44813793)
55
333
1.66
3.17
1.1
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
147
1090
1.35
3.15
3.1
2.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
56
345
1.63
3.04
1.1
1.1
—
—
—
0
0
(4133840)
29
146
1.99
3.04
1.2
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
419
3542
1.19
3.01
1.3
1.3
au/ml
41.8
55.6
—
10
151
(3000012) Reticulocyte production index
72
473
1.53
2.98
1.6
1.5
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
61
387
1.58
2.95
1.4
1.2
u/l
35.3
25.9
0.70
54
323
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
16
63
2.54
2.95
1.2
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
48
287
1.68
2.93
1.1
1.2
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
8
17
4.71
2.91
1.1
1.1
mmol/l
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
52
319
1.63
2.89
1.1
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
73
485
1.51
2.88
1.1
1.1
u/ml
4.9
4.1
0.13
27
205
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
18
76
2.37
2.88
2.3
2.0
umol/l
14.1
18.9
0.79
18
76
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
36
199
1.81
2.88
1.0
1.1
miu/ml
1603.2
1539.8
0.12
36
199
(3044009) aPTT.lupus sensitive (LA screen)
12
41
2.93
2.85
1.3
1.2
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
37
207
1.79
2.85
1.1
1.5
pmol/l
16.8
16.1
0.28
32
166
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
32
171
1.87
2.84
1.2
1.1
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
62
399
1.56
2.83
1.4
1.2
u/l
138.4
97.4
0.91
56
341
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
77
520
1.48
2.82
1.7
1.7
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
197
1549
1.28
2.82
3.0
3.1
u/ml
736.5
678.5
0.03
171
1413
(4094501)
130
1734
0.75
2.82
1.1
1.1
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
235
1889
1.25
2.80
5.2
3.5
mmol/l
1.6
1.7
1.41
229
1846
(21494227) Amikacin free [Mass/volume] in Serum or Plasma
8
18
4.45
2.79
4.4
4.9
mg/l
4.4
3.5
—
8
11
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
40
667
0.60
2.75
1.2
1.2
mmol/l
8.5
7.6
0.63
23
479
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
456
3917
1.17
2.74
2.4
2.4
au/ml
33.5
25.6
—
7
153
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
62
405
1.53
2.67
1.1
1.0
u/ml
0.9
0.5
0.26
11
124
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
167
1296
1.29
2.67
1.6
1.7
iu/l
3.3
4.6
1.95
53
406
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
21
99
2.12
2.64
1.1
1.1
u/ml
13.0
3.9
—
7
11
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
19
86
2.21
2.63
1.2
1.2
ug/l
127.4
107.9
0.21
11
55
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
31
169
1.84
2.62
1.2
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
229
1852
1.24
2.61
1.3
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
32
177
1.81
2.58
1.1
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
66
441
1.50
2.58
2.1
1.7
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
17
74
2.30
2.57
1.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
147
1128
1.31
2.57
4.1
2.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
94
673
1.40
2.56
1.5
1.4
%
33.1
27.4
0.75
58
432
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
43
260
1.66
2.56
2.1
1.6
nmol/l
6.3
6.5
0.03
34
216
(3046904) Somatotropin [Units/volume] in Serum or Plasma
5
7
7.14
2.55
2.8
1.4
mu/l
2.8
1.3
—
5
7
(21494890) Protein electrophoresis panel - 24 hour Urine
114
844
1.36
2.54
2.3
1.9
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
15
62
2.42
2.53
1.1
1.2
mmol/l
163.1
155.3
—
10
52
(3025315) Body weight
14
56
2.50
2.52
5.6
5.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
230
1870
1.24
2.51
1.3
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
32
179
1.79
2.50
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
229
1863
1.24
2.49
1.3
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
55
831
0.66
2.49
1.5
1.5
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
30
165
1.82
2.48
3.2
2.2
nmol/l
147.1
141.5
0.13
23
143
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
70
479
1.46
2.45
1.7
1.2
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
26
137
1.90
2.45
1.0
1.1
pmol/l
—
5.4
—
0
22
(3034891) Synovial lining cells/100 cells in Synovial fluid
51
326
1.57
2.45
1.5
1.4
%
1.7
3.8
1.03
11
78
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
818
9052
0.89
2.44
11.0
8.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
52
335
1.56
2.42
1.1
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
10
34
2.94
2.41
1.3
1.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
52
336
1.55
2.39
1.1
1.0
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
73
507
1.44
2.38
3.8
1.9
mmol/l
8.0
7.1
1.17
57
348
(3043410) Blood group antigens tested for on Red Blood Cells
37
220
1.68
2.36
1.8
1.8
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
20
97
2.06
2.36
2.3
2.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
15
65
2.31
2.31
2.2
3.2
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
17
78
2.18
2.30
1.3
1.2
mmol/l
7.6
6.3
—
7
35
(3013293) Extractable nuclear Ab [Presence] in Serum
17
78
2.18
2.30
2.1
1.5
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
31
177
1.75
2.29
1.4
1.2
%
37.1
32.5
0.24
20
120
(3049233) Organic acids panel - Urine
6
13
4.62
2.27
1.2
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
19
92
2.07
2.26
3.8
6.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
23
419
0.55
2.25
1.4
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
88
1196
0.73
2.24
1.5
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
29
164
1.77
2.22
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
72
1009
0.71
2.21
1.4
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
57
383
1.49
2.21
1.7
1.3
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
14
60
2.34
2.21
1.4
1.3
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
24
128
1.88
2.20
2.0
1.1
mmol/l
23.8
20.0
1.79
19
108
(40768793) Breast Pathology biopsy report
81
1112
0.73
2.20
1.4
1.3
—
—
—
0
0
(4146454)
110
831
1.33
2.20
2.7
2.8
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
54
360
1.50
2.18
1.1
1.1
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
18
87
2.07
2.16
1.2
2.5
mmol/l
0.8
1.9
—
10
58
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
18
87
2.07
2.16
1.2
1.2
%
76.0
52.3
—
5
40
(3023430) Cat dander IgE Ab [Units/volume] in Serum
65
451
1.44
2.16
1.1
1.1
u/ml
1.9
4.3
1.78
27
189
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
32
188
1.70
2.16
1.3
1.2
nmol/l
125.5
140.7
0.17
24
140
(3050129) First trimester maternal screen panel - Serum or Plasma
31
514
0.60
2.15
1.4
1.4
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
35
211
1.66
2.15
2.0
2.0
u/l
37.1
45.8
0.23
35
192
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
19
94
2.02
2.15
2.5
2.1
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
39
242
1.61
2.15
3.3
2.9
umol/l
29.8
29.0
0.17
29
179
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
298
3498
0.85
2.14
1.4
1.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
155
1232
1.26
2.12
1.8
1.7
mu/l
305.6
298.9
0.12
145
1133
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
117
897
1.31
2.12
3.2
2.5
u/ml
98.4
691.6
1.08
112
877
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
271
3201
0.84
2.10
1.9
1.9
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
116
890
1.31
2.09
1.2
1.1
iu/ml
79.3
240.3
0.45
31
188
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
11
43
2.56
2.09
1.3
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
64
447
1.43
2.07
8.0
12.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
24
420
0.57
2.06
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
24
419
0.57
2.05
1.4
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
58
399
1.46
2.03
1.6
1.6
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
24
418
0.57
2.03
1.4
1.4
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
16
76
2.11
2.02
1.1
1.1
iu/ml
4.2
12.6
0.93
11
32
(3028679) Herpes simplex virus Ab [Presence] in Serum
38
239
1.59
2.00
1.1
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
462
4079
1.14
2.00
2.6
2.5
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
61
426
1.43
1.98
1.1
1.0
mg/l
313.6
285.7
1.78
53
382
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
7
21
3.33
1.96
7.1
5.6
umol/l
425.4
434.6
—
7
21
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
25
141
1.78
1.96
2.6
3.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
18
91
1.98
1.94
1.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
39
249
1.57
1.94
1.1
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
32
195
1.64
1.92
1.3
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
15
71
2.11
1.91
1.1
1.0
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
50
340
1.47
1.88
1.2
1.2
u/l
184.3
303.4
1.14
45
310
(3034274) Bile acid [Moles/volume] in Serum --fasting
56
390
1.44
1.87
1.4
2.2
umol/l
11.0
11.7
0.10
46
274
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
23
129
1.78
1.85
1.2
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
68
492
1.38
1.84
3.1
2.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
36
229
1.57
1.83
1.1
1.1
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
47
318
1.48
1.82
1.0
1.1
iu/ml
13.1
11.3
0.20
12
75
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
365
3197
1.15
1.80
1.2
1.2
iu/ml
91.7
133.7
2.18
120
1119
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
15
73
2.06
1.80
1.1
1.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1463
13770
1.07
1.76
3.1
3.1
mmol/l
2.5
2.5
5.44
1254
11908
(3049242) von Willebrand panel - Platelet poor plasma
6
18
3.33
1.74
1.3
2.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
20
348
0.57
1.73
1.4
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
28
170
1.65
1.73
2.2
2.4
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
8
30
2.67
1.72
4.1
2.0
—
—
—
0
0
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
13
61
2.13
1.71
1.8
1.8
%
47.5
64.9
—
8
38
(3005033) Fetal Nuchal fold Thickness US
20
346
0.58
1.70
1.4
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
21
357
0.59
1.68
1.5
1.5
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
6
19
3.16
1.66
1.8
4.8
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
18
97
1.86
1.65
2.6
3.1
u/field
0.4
0.4
0.10
18
97
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
65
477
1.37
1.65
1.2
1.2
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
14
69
2.03
1.64
1.6
4.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
29
452
0.64
1.63
1.4
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
395
3508
1.13
1.62
2.9
2.9
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
26
158
1.65
1.61
1.1
1.1
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
211
1793
1.18
1.58
5.5
3.6
mmol/l
7.6
7.7
0.28
205
1759
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
174
0.46
1.57
1.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
20
337
0.59
1.56
2.1
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
358
4035
0.88
1.55
1.2
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
87
674
1.29
1.55
1.1
1.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
16
85
1.88
1.54
1.1
1.5
—
—
—
0
0
(3019174) dRVVT (LA screen)
10
44
2.27
1.53
1.1
1.2
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
5
15
3.33
1.52
2.2
4.9
—
—
—
0
0
(3002256) Pathology report gross observation
833
8973
0.92
1.50
1.3
1.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
29
186
1.56
1.48
1.3
1.2
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
9
37
2.43
1.47
1.1
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
204
1741
1.18
1.47
1.6
1.7
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
16
280
0.57
1.46
1.1
1.1
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
33
219
1.51
1.45
4.2
5.7
%
67.3
71.0
0.33
26
171
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
15
81
1.85
1.39
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
66
862
0.76
1.39
1.3
1.3
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
7
29
2.41
1.39
1.0
1.1
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
14
74
1.89
1.38
19.8
11.6
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
24
150
1.60
1.37
1.2
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
167
1412
1.19
1.37
1.1
1.1
u/ml
11.1
7.7
—
7
123
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
252
2876
0.87
1.36
1.8
1.8
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
27
406
0.66
1.33
1.4
1.4
pmol/l
62.4
132.7
0.48
12
133
(4024509)
88
699
1.26
1.33
1.6
1.6
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
80
630
1.27
1.30
1.4
1.6
u/ml
35.6
26.6
0.42
16
145
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
9
43
2.09
1.30
7.2
3.3
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
9
43
2.09
1.30
1.1
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
25
161
1.55
1.28
1.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
10
48
2.08
1.27
1.2
1.2
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
59
448
1.32
1.26
2.3
2.3
nmol/l
20.5
17.4
0.81
54
416
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
24
154
1.56
1.25
2.8
1.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
674
6251
1.08
1.25
3.9
3.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
46
337
1.37
1.24
3.7
3.7
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
6
25
2.40
1.24
2.3
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
133
1114
1.20
1.24
1.9
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
158
1344
1.18
1.24
1.6
1.4
iu/l
29.0
29.1
0.01
123
1127
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
17
278
0.61
1.23
1.5
1.5
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
9
45
2.00
1.23
1.0
1.0
—
—
—
0
0
(3036603) Volume of Urine
60
459
1.31
1.23
1.7
1.7
ml
1766.8
1887.0
0.24
16
137
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
22
139
1.58
1.22
1.0
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
8
37
2.16
1.21
1.0
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
16
93
1.72
1.20
1.2
1.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
14
78
1.80
1.20
1.3
1.6
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
28
188
1.49
1.20
1.2
1.3
%
46.4
24.4
—
5
21
(40768443) Skin Pathology biopsy report
340
3057
1.12
1.20
1.3
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
712
6637
1.08
1.17
2.3
2.2
ug/g
172.8
153.2
0.67
570
5187
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
5
20
2.50
1.15
1.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
26
380
0.68
1.14
1.3
1.5
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
87
706
1.23
1.13
1.3
1.3
e6/l
75190.8
172754.3
0.87
52
490
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
552
5965
0.92
1.13
1.6
1.6
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
35
483
0.72
1.12
1.1
1.0
ng/l
285.7
326.5
0.51
24
316
(4281824)
75
601
1.25
1.10
1.2
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
5113
51977
0.96
1.09
39.6
20.2
%
14.6
13.9
155.96
5027
50682
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
59
460
1.28
1.08
1.3
1.4
u/l
25.1
29.0
0.40
46
382
(3011335) Digoxin [Mass/volume] in Serum or Plasma
15
89
1.69
1.07
2.6
2.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
467
4300
1.09
1.06
3.5
3.0
e6/l
0.3
0.3
0.26
460
4215
(1617658) Protocol used for examination of sentinel lymph nodes
27
385
0.70
1.06
1.1
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
37
270
1.37
1.06
1.1
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
21
137
1.53
1.05
2.8
1.5
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
20
129
1.55
1.05
1.4
1.5
ng/l
102.6
145.2
1.27
20
129
(40768804) Tissue Pathology biopsy report
2556
26327
0.96
1.05
2.3
2.2
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
36
487
0.74
1.04
1.1
1.0
ng/l
33.1
44.3
1.18
25
314
(3000285) Sodium [Moles/volume] in Blood
18
114
1.58
1.02
1.2
1.1
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
36
485
0.74
1.01
1.1
1.0
ng/l
819.0
706.6
0.52
24
312
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
20
131
1.53
0.99
1.0
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
59
467
1.27
0.98
1.6
1.5
nmol/l
0.2
0.2
1.85
48
350
(3020123) Porphyrins [Interpretation] in Serum or Plasma
7
36
1.95
0.97
1.0
1.1
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
20
132
1.52
0.96
1.0
1.1
u/ml
1.2
1.0
0.05
12
71
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
9
50
1.80
0.96
1.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
38
285
1.33
0.94
1.5
1.4
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
7
37
1.89
0.94
1.0
1.0
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
361
3932
0.91
0.93
4.7
3.8
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
9
52
1.73
0.92
1.1
1.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
113
966
1.17
0.90
1.9
1.6
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
15
94
1.60
0.90
1.1
1.3
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
15
94
1.60
0.90
1.1
1.3
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
15
94
1.60
0.90
1.1
1.3
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
35
262
1.34
0.89
2.3
2.3
umol/l
57.4
56.2
0.07
29
207
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
11
64
1.72
0.86
1.4
1.1
u/l
10.6
9.8
0.05
11
64
(3036048) Francisella tularensis Ab [Titer] in Serum
19
128
1.49
0.85
1.1
1.1
—
580.0
—
0
6
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
12
190
0.63
0.82
1.5
1.4
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
8
47
1.70
0.80
1.1
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
8
47
1.70
0.80
1.5
1.2
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
24
0.00
0.79
0.0
1.1
—
8.3
—
0
24
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
8
48
1.67
0.78
1.0
1.1
—
—
—
0
0
(40758358) Immune stain study
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
14
90
1.56
0.78
1.2
1.2
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
34
261
1.30
0.76
1.1
1.1
ng/l
453.4
345.8
—
7
69
(3002619) Bacteria identified in Specimen by Culture
20
141
1.42
0.74
1.1
1.2
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
55
1.64
0.73
1.1
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
142
1598
0.89
0.73
3.2
2.3
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
5
25
2.00
0.72
2.4
1.3
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
16
109
1.47
0.70
1.3
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
11
169
0.65
0.68
1.4
1.1
—
—
—
0
0
(4211845)
46
374
1.23
0.67
3.7
3.6
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
24
179
1.34
0.66
2.6
2.3
mmol/l
7.5
7.8
0.12
15
117
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
50
412
1.21
0.65
2.2
2.1
ug/min
103.7
166.3
0.37
14
99
(3032868) Hemoglobin electrophoresis panel in Blood
7
44
1.59
0.65
1.7
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
19
137
1.39
0.64
1.1
1.2
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
5
29
1.72
0.64
1.0
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
20
146
1.37
0.63
1.1
1.2
—
—
—
0
0
(3022670) pH of Venous cord blood
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
55
653
0.84
0.61
1.1
1.1
u/ml
7.4
3.2
0.55
20
235
(3005011) Chlamydia sp Ab [Titer] in Serum
12
80
1.50
0.59
1.5
1.7
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
8
52
1.54
0.59
2.8
4.7
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
79
686
1.15
0.59
1.2
1.2
nmol/l
327.9
331.2
0.05
60
536
(40765096) Chromosome analysis panel by Banding
16
220
0.73
0.58
1.2
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
48
400
1.20
0.58
1.5
1.5
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
36
1.67
0.56
1.2
1.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
14
98
1.43
0.56
1.0
1.1
—
—
—
0
0
(4034850)
200
2171
0.92
0.56
18.1
11.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
11
73
1.51
0.56
1.1
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
890
8582
1.04
0.54
4.9
4.7
%
33.2
33.0
0.26
639
5612
(3027570) Oxalate [Moles/time] in 24 hour Urine
6
39
1.54
0.53
1.0
1.4
umol/24h
256.0
327.4
—
6
39
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
117
1053
1.11
0.52
1.1
1.2
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
39
468
0.83
0.51
8.2
3.5
%
13.8
13.3
1.70
39
463
(44806420)
21
270
0.78
0.51
2.0
2.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
21
162
1.30
0.49
1.0
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
11
76
1.45
0.48
1.2
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
53
457
1.16
0.46
1.5
1.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
42
356
1.18
0.45
1.2
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
6549
65093
1.02
0.43
37.1
16.6
mg/l
27.9
27.0
1.62
6096
53090
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
5
31
1.61
0.43
1.2
1.6
u/ml
2.4
1.7
—
5
26
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
44
377
1.17
0.43
1.3
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
4628
46716
0.98
0.42
5.7
4.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
29
239
1.21
0.42
2.2
1.7
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
18
140
1.29
0.41
1.1
1.2
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
11
150
0.73
0.41
1.2
1.5
mmol/l
7.5
8.6
—
6
91
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
5
34
1.47
0.40
1.2
1.1
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
5
35
1.43
0.39
1.0
1.5
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
14
106
1.32
0.39
1.0
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
9
66
1.36
0.38
1.7
1.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
72
649
1.11
0.36
1.2
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1627
16567
0.98
0.35
1.4
1.3
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
6
43
1.40
0.35
1.0
1.6
nmol/l
4.3
3.8
—
6
43
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
255
2681
0.95
0.34
1.1
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
15
189
0.79
0.34
1.4
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
140
1498
0.93
0.33
1.8
2.0
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
17
136
1.25
0.33
1.2
1.2
umol/24h
0.7
0.7
—
6
63
(3025130) Human papilloma virus identified in Specimen
39
446
0.87
0.33
1.8
1.7
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
6
46
1.30
0.33
1.2
1.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
6
88
0.68
0.33
1.0
1.1
—
—
—
0
0
(3001729) Color of Synovial fluid
10
74
1.35
0.32
1.1
1.4
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
33
285
1.16
0.32
4.8
5.1
u/ml
51.6
54.6
—
5
50
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
14
110
1.27
0.31
1.6
1.5
mu/l
353.5
410.5
0.21
14
105
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
108
1163
0.93
0.31
2.3
1.9
pmol/l
181.8
199.8
0.98
98
1076
(3014599) Egg white IgE Ab [Units/volume] in Serum
19
230
0.83
0.31
1.1
1.1
u/ml
4.2
1.5
—
8
77
(3029396) Erythrocyte agglutination [Presence] in Blood
7
53
1.32
0.30
2.3
2.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
137
1460
0.94
0.30
1.0
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
16
129
1.24
0.30
1.3
1.3
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
7
55
1.27
0.30
1.0
1.1
—
—
—
0
0
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
14
111
1.26
0.30
1.6
1.5
%
66.6
73.8
0.55
14
106
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
20
168
1.19
0.27
1.2
1.6
ug/l
9.4
9.3
0.03
20
168
(3025577) Chromium [Mass/volume] in Blood
44
490
0.90
0.27
1.8
2.0
ug/l
1.8
2.2
0.54
39
408
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
154
1625
0.95
0.26
1.8
1.7
mg/l
18.0
3.5
6.02
132
1162
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
43
477
0.90
0.25
4.4
5.0
u/ml
172.8
73.3
0.34
12
134
(1002224) Polysomnography panel
178
1867
0.95
0.25
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
268
2579
1.04
0.25
1.3
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
791
7744
1.02
0.25
1.5
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1452
14735
0.98
0.25
5.2
4.4
kg/l
1.0
1.0
1.10
284
2265
(3037556) Urate [Mass/volume] in Serum or Plasma
26
226
1.15
0.24
2.1
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
4798
47698
1.01
0.24
4.3
3.8
pmol/l
15.2
15.0
8.10
4333
42445
(40765089) Chromosome analysis panel - Blood by G-banded
6
85
0.71
0.24
1.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
14
169
0.83
0.23
1.2
1.3
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
46
506
0.91
0.23
1.7
1.9
ug/l
3.0
3.6
0.33
40
443
(3000034) Microalbumin [Mass/volume] in Urine
65
703
0.92
0.23
3.2
3.0
mg/l
59.1
56.1
0.04
52
525
(3020650) Glucose [Presence] in Urine
12
147
0.82
0.23
2.2
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
483
4706
1.03
0.23
3.9
3.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
10
79
1.27
0.22
1.5
1.5
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
42
1.19
0.21
1.0
1.5
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
5
42
1.19
0.21
1.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
21
241
0.87
0.21
1.0
1.2
u/ml
0.5
1.7
—
10
94
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
12
98
1.22
0.21
1.6
1.6
—
77.1
—
0
12
(3018291) Platelet Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
63
676
0.93
0.20
1.1
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
6
50
1.20
0.19
1.8
2.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
276
2676
1.03
0.19
2.7
3.3
u/ml
586.5
2570.9
1.10
235
2274
(42870560) Thyrotropin [Units/volume] in Cord blood
10
121
0.83
0.18
1.0
1.0
mu/l
9.1
8.9
—
10
113
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
218
2112
1.03
0.17
1.6
1.6
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
7
63
1.11
0.17
1.1
1.2
umol/24h
2.0
1.7
—
7
63
(3017446) Testosterone [Moles/volume] in Serum or Plasma
504
5140
0.98
0.17
2.5
2.1
nmol/l
11.7
12.1
0.48
432
4420
(3020961) Endomysium IgA Ab [Titer] in Serum
244
2510
0.97
0.16
1.1
1.1
titre
125.8
182.3
—
6
55
(3028717) Thiamine [Mass/volume] in Blood
8
71
1.13
0.16
1.0
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
10
83
1.20
0.15
1.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
29
265
1.09
0.14
1.0
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
216
2219
0.97
0.14
5.2
4.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
295
3017
0.98
0.14
2.6
2.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
1569
15804
0.99
0.11
4.5
3.8
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
11
96
1.15
0.10
1.5
1.4
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
6
55
1.09
0.08
1.0
1.0
g/l
170.5
164.5
—
6
55
(3015183) Erythrocyte sedimentation rate
19
206
0.92
0.08
1.0
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
61
632
0.96
0.07
1.1
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
31
294
1.05
0.07
3.3
2.6
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
8
90
0.89
0.06
1.0
1.0
kpa
3.3
3.2
—
8
79
(3006598) pH of Arterial cord blood
8
92
0.87
0.06
1.0
1.0
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
8
92
0.87
0.06
1.0
1.0
kpa
7.7
7.3
—
8
81
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
18
193
0.93
0.06
1.1
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
45
434
1.04
0.06
1.2
1.3
mmol/l
11.4
11.7
0.16
19
128
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
12
131
0.92
0.05
1.9
3.0
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
81
829
0.98
0.05
3.0
3.6
u/ml
36.2
35.0
0.04
76
804
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
117
1191
0.98
0.05
1.6
1.9
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
16
150
1.07
0.04
2.6
1.8
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
16
170
0.94
0.04
4.9
6.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
241
2393
1.01
0.03
2.6
3.8
u/ml
58.9
80.0
0.83
227
2293
(3003740) Influenza virus B Ag [Presence] in Specimen
62
631
0.98
0.02
1.1
1.1
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
12
127
0.94
0.01
1.9
1.9
mg/l
9.5
9.2
0.07
12
107
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
23
237
0.97
0.01
1.3
1.6
ug/l
2.0
4.8
1.34
15
189
(3051387) C reactive protein [Mass/volume] in Capillary blood
165
1641
1.01
0.01
5.7
3.7
mg/l
30.3
30.0
0.03
110
1078
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
16
161
0.99
0.00
1.0
1.1
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
19
186
1.02
0.00
1.1
1.1
u/ml
0.3
3.6
—
5
30
(40762814) Titanium [Mass/volume] in Blood
13
133
0.98
0.00
1.9
2.1
ug/l
3.8
3.7
—
5
48
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
10
100
1.00
0.00
1.7
3.2
ng/l
96.9
159.0
—
5
50
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
30
300
1.00
0.00
1.1
1.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
168
1682
1.00
0.00
1.9
1.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
553
5534
1.00
0.00
3.7
2.8
ml/min/173m2
59.2
61.5
0.36
248
2327
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
25
252
0.99
0.00
1.2
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
34
340
1.00
0.00
5.1
6.4
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
37.2
—
0
6
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
45.3
—
0
6
(3034614) HLA Ag [Interpretation]
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043614) Bacteria identified in Aspirate by Culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
6.6
—
0.2
—
0
8
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
6
69
0.87
0.00
1.5
1.8
—
—
—
0
0
(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021691) Plasmodium malariae Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3007147) Virus identified in Stool by Electron microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4212803)
7
77
0.91
0.00
1.0
1.1
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
134.8
—
0
5
(3040794) Aluminum [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
6
69
0.87
0.00
1.0
1.0
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002814) Trichinella spiralis Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
17.0
—
0
5
(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count
0
5
0.00
0.00
0.0
5.8
—
14.0
—
0
5
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint J10_RESPOTHER and mortality.

Females

Parameter HR [95% CI] p-value
J10_RESPOTHER 5.137 [4.57, 5.78] < 0.001
Birth year 0.998 [0.99, 1.01] 0.514

During the follow-up period (1.1.1998 — 31.12.2019), 9925 out of 18310 females with J10_RESPOTHER died.

Males

Parameter HR [95% CI] p-value
J10_RESPOTHER 4.612 [4.05, 5.26] < 0.001
Birth year 0.984 [0.98, 0.99] < 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 14174 out of 24103 males with J10_RESPOTHER died.

Mortality risk

Mortality risk for people of age

years, who have J10_RESPOTHER.

N-year risk Females Males
1 0.4% 0.689%
5 3.089% 4.082%
10 7.873% 10.889%
15 14.345% 20.729%
20 23.448% 31.83%

Relationships between endpoints

Index endpoint: J10_RESPOTHER – Other diseases of the respiratory system

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data